Original Article
Survival of Patients with Stage I Lung Cancer Detected on CT Screening
N Engl J Med 2006; 355:1763-1771October 26, 2006
- Abstract
Background
The outcome among patients with clinical stage I cancer that is detected on annual screening using spiral computed tomography (CT) is unknown.
Methods
In a large collaborative study, we screened 31,567 asymptomatic persons at risk for lung cancer using low-dose CT from 1993 through 2005, and from 1994 through 2005, 27,456 repeated screenings were performed 7 to 18 months after the previous screening. We estimated the 10-year lung-cancer–specific survival rate among participants with clinical stage I lung cancer that was detected on CT screening and diagnosed by biopsy, regardless of the type of treatment received, and among those who underwent surgical resection of clinical stage I cancer within 1 month. A pathology panel reviewed the surgical specimens obtained from participants who underwent resection.
Results
Screening resulted in a diagnosis of lung cancer in 484 participants. Of these participants, 412 (85%) had clinical stage I lung cancer, and the estimated 10-year survival rate was 88% in this subgroup (95% confidence interval [CI], 84 to 91). Among the 302 participants with clinical stage I cancer who underwent surgical resection within 1 month after diagnosis, the survival rate was 92% (95% CI, 88 to 95). The 8 participants with clinical stage I cancer who did not receive treatment died within 5 years after diagnosis.
Conclusions
Annual spiral CT screening can detect lung cancer that is curable.
Media in This Article
Figure 1
Diagnoses of Lung Cancer Resulting from Baseline Screening and Annual Screening with CT.Figure 2
Kaplan–Meier Survival Curves for 484 Participants with Lung Cancer and 302 Participants with Clinical Stage I Cancer Resected within 1 Month after Diagnosis.Article Activity
- Article
In 1993, the Early Lung Cancer Action Project (ELCAP) initiated a study of the early diagnosis of lung cancer in cigarette smokers with the use of annual screening with spiral computed tomography (CT).1,2 The principal finding was that more than 80% of persons given a diagnosis of lung cancer as a result of annual CT screening had clinical stage I cancer.3 This result has been confirmed by others4 who have adopted the updated protocol.5,6 The question remains, however, whether early intervention in such patients is sufficiently effective to justify screening large asymptomatic populations who are at risk for lung cancer.7,8 We report the results of all patients in the study with stage I lung cancer detected with the use of spiral CT screening, including those who underwent surgical resection.
Methods
Screening was defined according to the International ELCAP (I-ELCAP) protocol6 so that data from participating institutions could be pooled. Each institution was required to document the initiation of screening in each participant and all subsequent screenings of that participant for as long as the screening continued, transmit the data and images to the coordinating center at Weill Medical College of Cornell University by means of the study's Web-based management system for CT screening for lung cancer,9 submit pathological specimens to the coordinating center, and follow quality-assurance procedures specified by the protocol. All participants gave written informed consent, and the institutional review board at each participating institution approved the protocols (Figure 1Figure 1
Diagnoses of Lung Cancer Resulting from Baseline Screening and Annual Screening with CT.).The protocol specified a common regimen of screening but allowed each participating institution to specify its criteria for enrollment. The regimen included the technical variables for the initial low-dose spiral CT scan, which were the same for the baseline and annual screenings. However, the definition of a positive result on the initial CT scan and the diagnostic workup leading to a diagnosis of lung cancer were different for the baseline screening and annual screening.
For baseline screening, a positive result on the initial low-dose CT scan was defined as the identification of at least one solid or partly solid noncalcified pulmonary nodule 5 mm or more in diameter, at least one nonsolid noncalcified pulmonary nodule 8 mm or more in diameter, or a solid endobronchial nodule.10 If none of the noncalcified nodules identified met the study criteria for a positive result or if the test was negative, CT was repeated 12 months later. The diameter of the nodule was defined as the average of the length and width of the cross-sectional area of the largest nodule in the CT images. The consistency of the nodule was defined as solid if the nodule obscured the entire lung parenchyma, partly solid if it obscured part of the lung parenchyma, and nonsolid if it obscured none of the parenchyma.11 If the result was positive, the type of workup depended on the diameter of the largest nodule. For nodules 5 to 14 mm in diameter, the preferred option was to perform another CT at 3 months; if the images showed growth of the nodule,12 then biopsy, ideally by fine-needle aspiration, was to be performed, whereas if there was no growth, the workup was stopped. The other option was to perform positron-emission tomography (PET) immediately, and if the results were positive, biopsy was to be performed; otherwise, CT was to be performed at 3 months. For nodules 15 mm in diameter or larger (whether solid, partly solid, or nonsolid), immediate biopsy was an option in addition to the options already specified for smaller nodules. When infection was suspected, a 2-week course of antibiotics followed 1 month later by CT was an alternative to all the options mentioned,13 and if no resolution or growth was observed, biopsy was to be performed; otherwise, the workup was stopped. For all participants for whom the workup was stopped or for whom the biopsy did not lead to a diagnosis of lung cancer, CT was to be repeated 12 months after the baseline CT.
For annual screenings, a positive result was considered to be any newly identified noncalcified nodule, regardless of size. If no new nodule was identified, CT was to be repeated 12 months later. If one or more new nodules were identified, the workup depended on the diameter of the largest nodule. If all nodules were less than 3.0 mm in diameter, or if the largest nodule was more than 3.0 mm but less than 5.0 mm in diameter, CT 6 or 3 months later, respectively, was to be performed. If no growth was seen in any of the nodules, the workup was stopped. If at least one of the noncalcified nodules was 5.0 mm or larger in diameter, then an immediate 2-week course of a broad-spectrum antibiotic was prescribed, followed 1 month later by CT. If the nodules showed no resolution or growth, biopsy was to be performed; otherwise, the workup was stopped. PET was an alternative to immediate biopsy; if the result was positive, biopsy was to follow. If the result was indeterminate or negative, CT was to be performed 3 months later, and if the scans showed growth, biopsy was to follow. Otherwise, the workup was stopped. For all patients for whom the workup was stopped or when biopsy did not result in a diagnosis of lung cancer, CT was to be repeated 12 months after the previous annual CT.
The protocol provided recommendations for the diagnostic workup in participants with a positive result on CT, with the decision regarding how to proceed left to each participant and the referring physician. The I-ELCAP protocol did not require that its recommendations for the workup of a nodule be followed, but it did require a firmly established final diagnosis of lung cancer and documentation of the workup in the management system. After the diagnosis of lung cancer was established, the type of intervention, if any, was left to the discretion of the participant and the physician. Documentation in the management system of the timing and type of intervention, if any, and follow-up with respect to manifestations of spread or death up to 10 years after diagnosis, were required.
A total of 31,567 asymptomatic men and women underwent baseline screening between 1993 and 2005 (median, 2001). The participants, who were 40 years of age and older, were at risk for lung cancer because of a history of cigarette smoking, occupational exposure (to asbestos, beryllium, uranium, or radon), or exposure to secondhand smoke without having smoked themselves; in Azumi, Japan, they participated as part of the annual health screening program (Table 1Table 1
I-ELCAP Participants, According to the Smoking Status, Exposure to Secondhand Smoke, and Occupational Exposures.). All participants were considered fit to undergo thoracic surgery. A total of 27,456 annual screenings were conducted between 1994 and 2005 (median, 2002), each of which was performed 7 to 18 months after the previous screening. At baseline, the median age of the participants was 61 years (range, 40 to 85), and the median number of pack-years of smoking was 30 (range, 0 to 141); on annual CT, the median values were an age of 62 years (range, 41 to 86) and 35 pack-years (range, 0 to 141). Among the participants, 13% (4186 of 31,567) who underwent baseline CT and 5% (1460 of 27,456) who underwent annual CT had a positive result that required immediate further workup. A biopsy of a pulmonary nodule as recommended in the protocol was performed in 535 of the participants with a positive result on the baseline or annual CT and led to a diagnosis of malignant disease in 492 of the participants (lung cancer was diagnosed in 479 and lymphoma or metastases from cancers other than lung cancer in 13) and no evidence of malignant disease in 43. The diagnosis was classified as having been identified during baseline screening when the nodule was first identified on the baseline CT, even for cases not meeting the criteria for a positive result, regardless of when the diagnosis was made. When the nodule was first identified on an annual CT, it was attributed to the annual screening. If the result on the baseline or annual CT was negative and a diagnostic workup was subsequently prompted by suggestive symptoms (or incidental findings) before the next scheduled annual CT, the finding was classified as an interim diagnosis. To fully document interim diagnoses of lung cancer, the protocol required that each enrolled participant who had not returned for the next scheduled screening be contacted 1 year after the previous screening. If contact could not be made either directly or through relatives of the participant, the referring physician was contacted to ascertain whether a diagnosis of lung cancer had been made.We determined the distribution of the baseline and annual screenings and the resulting diagnoses according to age and median pack-years of cigarette smoking (Table 2Table 2
Frequency Distribution of Lung-Cancer Diagnoses on Baseline and Annual CT Screening, According to Age and Median Pack-Years of Cigarette Smoking.). Each diagnosis of lung cancer was classified according to clinical stage with the use of standard criteria based on the clinical examination and the results of imaging.14 The presence or absence of lymph-node (N) and distant metastases (M) was assessed on the most recent CT obtained before diagnosis and from PET (performed in 166 of the 484 participants who received a diagnosis of lung cancer). The cancer was classified as N0M0 if on CT the widths of all mediastinal lymph nodes were less than 10 mm and no hilar lymph nodes or distant metastases were identified (and PET, if performed, showed no abnormal uptake). For the purpose of this study, stage I cancers included those classified as N0M0 with more than 1 adenocarcinoma so long as all adenocarcinomas were 30 mm or less in diameter.6 The specimens obtained from participants who underwent surgical resection were examined at each institution according to the I-ELCAP pathology protocol,15 which specified the preparation of the specimen and the findings that were to be documented by the pathologist at the hospital where the resection was performed. The protocol also specified the review process: a five-member pathology-review panel consisting of expert pulmonary pathologists was to reach a consensus diagnosis for each case of cancer and identify lymph-node involvement, additional cancers, and pleural, lymphatic, vascular, bronchial, and basement-membrane invasion by the cancer. For 22 of the 411 participants who underwent resection (5%), specimens could not be obtained from a nonparticipating hospital, and the panel therefore reviewed the detailed surgical and pathological reports for the relevant information.
All patients given a diagnosis of lung cancer were followed annually by the principal investigator and by the study coordinator at each participating institution, who submitted the information required by the protocol to the coordinating center. When a participant was known to have died, the date and cause were obtained from the participant's physician, family members, or both. Death resulting from treatment was considered to have been caused by lung cancer. Follow-up from diagnosis to death from lung cancer, the last contact, or May 30, 2006, whichever came first, was documented for each participant. The duration of follow-up ranged from 1 to 123 months (median, 40).
Kaplan–Meier curves were calculated for lung-cancer–specific survival as of the date of diagnosis, irrespective of the type of treatment, including no treatment, for all participants with lung cancer, irrespective of the stage of the cancer, and for the subgroup with clinical stage I cancer. Survival curves were also calculated for participants who underwent resection of clinical stage I cancer within 1 month after diagnosis and those who did not receive treatment. On the basis of these curves, we estimated the 10-year survival rates. The curves were constructed with the use of SAS statistical software (version 8), which also produced the standard error for the estimates.
Results
Baseline screening of 31,567 asymptomatic persons who were at risk for lung cancer and annual screening of 27,456 resulted in the diagnosis of lung cancer in 405 and 74 participants, respectively (Figure 1). Another five participants received interim diagnoses of lung cancer that were prompted by the development of symptoms within 12 months after the baseline screening. Of these 484 participants given a diagnosis of lung cancer, 411 underwent resection; 57 received radiation, chemotherapy, or both; and 16 received no treatment. Because survival rates among the participants who underwent baseline screening and those who underwent annual screening did not differ significantly, Kaplan–Meier estimates of lung-cancer–specific survival were calculated for all 484 participants (Figure 2Figure 2
Kaplan–Meier Survival Curves for 484 Participants with Lung Cancer and 302 Participants with Clinical Stage I Cancer Resected within 1 Month after Diagnosis.). The estimated 10-year survival rate for all participants, regardless of tumor stage and treatment, was 80% (95% confidence interval [CI], 74 to 85); as of May 2006, 75 of the 484 participants had died of lung cancer, including 2 who died within 4 weeks after surgery, yielding an operative mortality rate of 0.5% (2 of 411 participants).Of the 484 participants who received a diagnosis of lung cancer, 412 (85%) had clinical stage I lung cancer. In this subgroup, the estimated 10-year survival rate regardless of treatment was 88% (95% CI, 84 to 91); as of May 2006, 39 of these 412 patients had died of lung cancer. Of these 412 participants, 375 had undergone surgical resection (284 lobectomy, 60 wedge resection, 21 segmentectomy, and 10 bilobectomy); 29 did not undergo resection but received chemotherapy, radiation, or both; and the remaining 8 did not receive treatment. Figure 2 also shows the lung-cancer–specific survival rate among the 302 participants who underwent resection within 1 month after diagnosis, among whom the estimated 10-year survival rate was 92% (95% CI, 88 to 95). All eight untreated patients died within 5 years after diagnosis.
Among the 412 participants with clinical stage I cancer, the distribution according to the type of cell is shown in Table 3Table 3
Types of Cancer among 412 Participants with Clinical Stage I Lung Cancer Detected on Baseline or Annual CT Screening.. The median tumor diameter was 13 mm at baseline and 9 mm on annual CT. The pathology-review panel confirmed the diagnosis of clinical stage I cancer in the specimens obtained from the 375 participants who underwent resection according to World Health Organization criteria of 2004.16 With regard to spread or invasion (Table 4Table 4
Extent of Spread of Cancer in 375 Participants Who Underwent Resection of Clinical Stage I Lung Cancer According to Whether Cancer was Detected on Baseline or Annual CT Screening.), the panel identified lymph-node metastases (hilar or ipsilateral mediastinal) in 28 participants (7%) and more than one cancer, either in the same or in different lobes, in another 35 (9%). Among the remaining participants, each with a solitary cancer, the panel identified invasion of the pleura in 62 (17%); bronchial, vascular, or lymphatic invasion or a combination in another 28 (7%); invasion of the basement membrane alone in 203 (54%), and no invasion in the remaining 19 (5%). (Because of rounding, percentages may not total 100.) Thus, of the 375 participants who underwent resection, 347 had pathological stage I cancer, and their estimated 10-year survival rate was 94% (95% CI, 91 to 97).Discussion
In making decisions about instituting CT screening for lung cancer, a major consideration is the outcome of treating a cancer detected on screening. In our study, the estimated 10-year lung-cancer–specific survival rate among the 484 participants with disease diagnosed on CT, regardless of the stage at diagnosis or type of treatment (including no treatment), was 80% (95% CI, 74 to 85) (Figure 2). Among the 412 participants with clinical stage I lung cancer — the only stage at which cure by surgery is highly likely — the estimated 10-year survival rate was 88% (95% CI, 84 to 91), and among those with clinical stage I lung cancer who underwent surgical resection within 1 month after the diagnosis, the rate was 92% (95% CI, 88 to 95). The diagnosis of lung cancer of one type or another was verified by a panel of five expert pulmonary pathologists. In our series, the operative mortality rate was low — 0.5% — and was less than the 1.0% reported with lobectomy in a large cooperative study.17
Sobue et al.18 reported a 5-year survival rate of 100% in their series of 29 patients who underwent resection after pathological stage I cancer was detected on CT. Before CT screening, reports based on registries showed 10-year survival rates of 80% among 17 patients with pathological stage I lung cancer 20 mm or less in diameter19 and 93% among 35 patients with pathological stage I cancer less than 10 mm in diameter.20 The National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) registry, the largest U.S. cancer registry, reported an 8-year survival rate of 75% among patients with pathological stage I cancer with nodules less than 15 mm in diameter who had undergone resection.8 Although the lung cancers in these three series were not detected on CT screening, most were presumably incidentally detected on imaging performed for other reasons in people who had no symptoms of lung cancer.
CT screening according to the I-ELCAP regimen can detect clinical stage I lung cancer in a high proportion of persons when it is curable by surgery. In a population at risk for lung cancer, such screening could prevent some 80% of deaths from lung cancer. In comparison, in the United States at present, annually approximately 173,000 persons are diagnosed with lung cancer and 164,000 deaths are attributed to this disease,21 so that approximately 95% of those who are diagnosed with lung cancer die from it.
Are these results sufficiently effective to justify screening people who are at risk of lung cancer? As compared with mammographic screening for breast cancer, for lung cancer the rates of detection among the participants in this study who were 40 years of age and older were 1.3% on baseline CT screening and 0.3% on annual screening (Table 2), values that were slightly higher than those for the detection of breast cancer (0.6 to 1.0% on baseline screening) and similar to those for annual screening (0.2 to 0.4%) among women 40 years of age and older.22 The rate of cancer detection depends on the risk profile of those undergoing screening; the higher the risk, the more productive the screening. Thus, as expected, CT screening of the original participants in ELCAP, who were former and current smokers 60 years of age and older,1,2 was more productive in detecting lung cancer (detection rates, 2.7% on baseline screening and 0.6% on annual screening) than among participants in the expanded study. The cost of low-dose CT is below $200,23-26 and surgery for stage I lung cancer is less than half the cost of late-stage treatment.26,27 Using the original ELCAP data and the actual hospital costs for the workup, we found CT screening for lung cancer to be highly cost-effective.23 Other estimates of the cost-effectiveness of CT screening for lung cancer for various risk profiles24-26,28 are similar to that for mammography screening.29,30
Supported in part by the National Institutes of Health (grants R01-CA-633931, to Dr. Henschke, and R01-CA-78905, to Dr. Yankelevitz); the Department of Energy (DE-FG02-96SF21260, to Dr. Markowitz); the Department of Defense to Dr. Tockman; Department of Health and Mental Hygiene of the City of New York; New York State Office of Science, Technology, and Academic Research; American Cancer Society; Israel Cancer Association; Starr Foundation; New York Community Trust; Rogers Family Fund; Foundation for Lung Cancer: Early Detection, Prevention, and Treatment; Foundation for Early Detection of Lung Cancer; Dorothy R. Cohen Foundation; Research Foundation of Clinic Hirslanden; Clinic Hirslanden; Swedish Hospital; Yad-Hanadiv Foundation; Jacob and Malka Goldfarb Charitable Foundation; Auen–Berger Foundation; Princess Margaret Foundation; Tenet Healthcare Foundation; Ernest E. Stempel Foundation, Academic Medical Development; Empire Blue Cross and Blue Shield; Eastman Kodak; General Electric; Weill Medical College of Cornell University; New York Presbyterian Hospital; Christiana Care Helen F. Graham Cancer Center; Holy Cross Hospital; Eisenhower Hospital; Jackson Memorial Hospital Health System; and Evanston Northwestern Healthcare.
Drs. Henschke and Yankelevitz receive royalties from Cornell Research Foundation as inventors of methods to assess tumor growth and regression on imaging tests for which pending patents are held by Cornell Research Foundation and licensed to General Electric.
No other potential conflict of interest relevant to this article was reported.
Source Information
The members of the Writing Committee (Claudia I. Henschke, M.D., Ph.D., David F. Yankelevitz, M.D., Daniel M. Libby, M.D., Mark W. Pasmantier, M.D., and James P. Smith, M.D., New York Presbyterian Hospital–Weill Medical College of Cornell University, New York; and Olli S. Miettinen, M.D., Ph.D., McGill University, Montreal) of the International Early Lung Cancer Action Program assume responsibility for the overall content and integrity of the article.
Address reprint requests to Dr. Henschke at New York Presbyterian Hospital–Weill Medical College of Cornell University, 525 E. 168th St., New York, NY 10021, or at chensch@med.cornell.edu.
The International Early Lung Cancer Action Program investigators are listed in the Appendix.
Appendix
The following investigators participated in I-ELCAP: Joan and Sanford I. Weill Medical College of Cornell University, New York: C.I. Henschke (principal investigator), D.F. Yankelevitz, D.I. McCauley; Azumi General Hospital, Nagano, Japan: S. Sone, T. Hanaoka; Center for the Biology of Natural Systems, City University of New York at Queens College, Queens: S. Markowitz, A. Miller; LungenZentrum Hirslanden, Zurich: K. Klingler, T. Scherer, R. Inderbitzi; Clinica Universitaria de Navarra, Pamplona, Spain: J. Zulueta, L. Montuenga, G. Bastarrika; National Cancer Institute Regina Elena, Rome: S. Giunta, M. Crecco, P. Pugliese; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL: M. Tockman; Hadassah Medical Organization, Jerusalem, Israel: D. Shaham; Swedish Medical Center, Seattle: K. Rice, R. Aye; University of Toronto, Princess Margaret Hospital, Toronto: H. Roberts, D. Patsios; Christiana Care Helen F. Graham Cancer Center, Newark, DE: T. Bauer, J. Lally; Columbia University Medical Center, New York: J.H.M. Austin, G.D.N. Pearson; New York University Medical Center, New York: D. Naidich, G. McGuinness; State University of New York at Stony Brook, Stony Brook: M. Rifkin, E. Fiore; Maimonides Medical Center, Brooklyn, NY: S. Kopel; Roswell Park Cancer Institute, Buffalo, NY: D. Klippenstein, A. Litwin, P.A. Loud; State University of New York Upstate Medical University, Syracuse: L.J. Kohman, E.M. Scalzetti; North Shore–Long Island Jewish Health System, New Hyde Park, NY: A. Khan, R. Shah; Georgia Institute for Lung Cancer Research, Atlanta: M.V. Smith, H.T. Williams, L. Lovett; Mount Sinai School of Medicine, New York: D.S. Mendelson; Jackson Memorial Hospital, University of Miami, Miami: R. Thurer; Memorial Sloan-Kettering Cancer Center, New York: R.T. Heelan, M.S. Ginsberg; Holy Cross Hospital Cancer Institute, Silver Spring, MD: F. Sullivan, M. Ottinger; Eisenhower Lucy Curci Cancer Center, Rancho Mirage, CA: D. Vafai; New York Medical College, Valhalla: T.A.S. Matalon; Mount Sinai Comprehensive Cancer Center, Miami Beach, FL: S.-L. Odzer; Fifth Affiliated Hospital (Zhuhai Hospital), of Sun Yat-Sen University, Zhuhai, China: X. Liu; Dorothy E. Schneider Cancer Center, Mills-Peninsula Health Services, San Mateo, CA: B. Sheppard; St. Agnes Cancer Center, Baltimore: E. Cole; Our Lady of Mercy Medical Center, Bronx, NY: P.H. Wiernik; Evanston Northwestern Healthcare Medical Group, Evanston, IL: D. Ray; Karmanos Cancer Institute, Detroit: H. Pass, C. Endress; Greenwich Hospital, Greenwich, CT: D. Mullen; Sharp Memorial Hospital, San Diego, CA: M. Kalafer; City of Hope National Medical Center, Duarte, CA: F. Grannis, A. Rotter; ProHealth Care Regional Cancer Center, Waukesha and Oconomowoc Memorial Hospitals, Oconomowoc, WI: M.K. Thorsen, R. Hansen; Comprehensive Cancer Center, Desert Regional Medical Center, Palm Springs, CA: E. Camacho; St. Joseph Health Center, St. Charles, MO: D. Luedke; Coordinating Center: C.I. Henschke, N. Altorki, A. Farooqi, J. Hess, D. Libby, D.I. McCauley, O.S. Miettinen, J. Ostroff, M.W. Pasmantier, A.P. Reeves, J.P. Smith, M. Vazquez, D.F. Yankelevitz, R. Yip, L. Zhang, K. Agnello; Pathology Review Panel: D. Carter, E. Brambilla, A. Gazdar, M. Noguchi, W.D. Travis.
- References
References
1
Henschke CI ,McCauley DI ,Yankelevitz DF , et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105
CrossRef | Web of Science | Medline2
Henschke CI ,Naidich DP ,Yankelevitz DF , et al. Early Lung Cancer Action Project: initial findings on repeat screening. Cancer 2001;92:153-159
CrossRef | Web of Science | Medline3
Henschke CI ,Yankelevitz DF ,Smith JP , et al. CT screening for lung cancer: assessing a regimen's diagnostic performance. Clin Imaging 2004;28:317-321
Web of Science | Medline4
Henschke CI, Yankelevitz DF, Miettinen OS, I-ELCAP Investigators
CrossRef | Web of Science | Medline5
Henschke CI, Yankelevitz DF, Smith JP, Miettinen OS, ELCAP Group
CrossRef | Web of Science | Medline6
International Early Lung Cancer Action Program protocol. (Accessed September 29, 2006, at http://www.IELCAP.org.)
7
Henschke CI, Yankelevitz DF, Smith JP, Miettinen OS. The use of spiral CT in lung cancer screening. In: DeVita VT, Hellman S, Rosenberg SA, eds. Progress in oncology 2002. Sudbury, MA: Jones and Barlett, 2002.
8
Henschke CI ,Wisnivesky JP ,Yankelevitz DF ,Miettinen OS . Screen-diagnosed small stage I cancers of the lung: genuineness and curability. Lung Cancer 2003;39:327-330
CrossRef | Web of Science | Medline9
Reeves AP, Kostis WJ, Yankelevitz DF, Henschke CI. A Web-based data system for multi-institutional research studies on lung cancer. Presented at the 87th annual meeting of the Radiologic Society of North America, Chicago, November 25–30, 2001.
10
Henschke CI ,Yankelevitz DF ,Naidich D , et al. CT screening for lung cancer: suspiciousness of nodules at baseline according to size. Radiology 2004;231:164-168
CrossRef | Web of Science | Medline11
Henschke CI ,Yankelevitz DF ,Mirtcheva R ,McGuinness G ,McCauley DI ,Miettinen OS . CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002;178:1053-1057
Web of Science | Medline12
Kostis WJ ,Yankelevitz DF ,Reeves AP ,Fluture SC ,Henschke CI . Small pulmonary nodules: reproducibility of three-dimensional volumetric measurement and estimation of time to follow-up CT. Radiology 2004;231:446-452
CrossRef | Web of Science | Medline13
Libby DM ,Wu N ,Lee IJ , et al. CT screening for lung cancer: the value of short-term CT follow-up. Chest 2006;129:1039-1042
CrossRef | Web of Science | Medline14
Mountain CF . Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717
CrossRef | Web of Science | Medline15
Vazquez M ,Flieder D ,Travis W , et al. Early Lung Cancer Action Project pathology protocol. Lung Cancer 2003;39:231-232
CrossRef | Web of Science | Medline16
Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC, eds. World Health Organization classification of tumours: pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon, France: IARC Press, 2004.
17
Allen MS ,Darling GE ,Pechet TT , et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ASOSOG Z0030 trial. Ann Thorac Surg 2006;81:1013-1020
CrossRef | Web of Science | Medline18
Sobue T ,Moriyama N ,Kaneko M , et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 2002;20:911-920
CrossRef | Web of Science | Medline19
Buell PE . The importance of tumor size in prognosis for resected bronchogenic carcinoma. J Surg Oncol 1971;3:539-551
CrossRef | Medline20
Martini N ,Bains MS ,Burt ME , et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-129
CrossRef | Web of Science | Medline21
Cancer facts and figures: statistics, 2005. Atlanta: American Cancer Society, 2005. (Also available at http://www.cancer.org.)
22
Quality determinants of mammography. In: Clinical practice guideline no. 13. Rockville, MD: Agency for Health Care Policy and Research, 1994:82-6. (Publication no. 95-0632.)
23
Wisnivesky JP ,Mushlin A ,Sicherman N ,Henschke CI . Cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening. Chest 2003;124:614-621
CrossRef | Web of Science | Medline24
Miettinen OS . Screening for lung cancer: can it be cost-effective? CMAJ 2000;162:1431-1436
Web of Science | Medline25
Marshall D ,Simpson KN ,Earle CC ,Chu C . Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort. Lung Cancer 2001;32:227-236
CrossRef | Web of Science | Medline26
Marshall D ,Simpson KN ,Earle CC ,Chu C . Economic decision analysis model of screening for lung cancer. Eur J Cancer 2001;37:1759-1767
CrossRef | Web of Science | Medline27
Riley GF ,Potosky AL ,Lubitz JD ,Kessler LG . Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care 1995;33:828-841
CrossRef | Web of Science | Medline28
Chirikos TN ,Hazelton T ,Tockman M ,Clark R . Screening for lung cancer with CT: a preliminary cost-effectiveness analysis. Chest 2002;121:1507-1514
CrossRef | Web of Science | Medline29
Lindfors KK ,Rosenquist CJ . The cost-effectiveness of mammographic screening strategies. JAMA 1995;274:881-884[Erratum, JAMA 1996;275:112.]
CrossRef | Web of Science | Medline30
Rosenquist CJ ,Lindfors KK . Screening mammography beginning at age 40 years: a reappraisal of cost-effectiveness. Cancer 1998;82:2235-2240
CrossRef | Web of Science | Medline
- Citing Articles (296)
Citing Articles
1
C. I. Henschke. (2012) Re: Inconsistencies in Findings from the Early Lung Cancer Action Project Studies of Lung Cancer Screening. JNCI Journal of the National Cancer Institute
CrossRef2
P. B. Bach. (2012) Response. JNCI Journal of the National Cancer Institute
CrossRef3
John K. Field, Robert A. Smith, Denise R. Aberle, Matthijs Oudkerk, David R. Baldwin, David Yankelevitz, Jesper Holst Pedersen, Scott James Swanson, William D. Travis, Ignacio I. Wisbuba, Masayuki Noguchi, Jim L. Mulshine. (2012) International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 Report. Journal of Thoracic Oncology 7:1, 10-19
CrossRef4
Daryl Phillip Pearlstein, Curtis C. Quinn, Charles C. Burtis, Kwang Woo Ahn, Aaron J. Katch. (2012) Electromagnetic Navigation Bronchoscopy Performed by Thoracic Surgeons: One Center's Early Success. The Annals of Thoracic Surgery
CrossRef5
Jerome M. Reich, Jong-Sung Kim. (2011) Lung cancer growth dynamics. European Journal of Radiology 80:3, e458-e461
CrossRef6
David J. Sher, Jon O. Wee, Rinaa S. Punglia. (2011) Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non–Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 81:5, e767-e774
CrossRef7
Arjun Nair, David M. Hansell. (2011) European and North American lung cancer screening experience and implications for pulmonary nodule management. European Radiology 21:12, 2445-2454
CrossRef8
David E. Midthun. (2011) Screening for Lung Cancer. Clinics in Chest Medicine 32:4, 659-668
CrossRef9
Susan Henderson, Amy DeGroff, Thomas B. Richards, Julia Kish-Doto, Cindy Soloe, Christina Heminger, Elizabeth Rohan. (2011) A Qualitative Analysis of Lung Cancer Screening Practices by Primary Care Physicians. Journal of Community Health 36:6, 949-956
CrossRef10
Ryoichi Kondo, Kazuo Yoshida, Satoshi Kawakami, Takayuki Shiina, Makoto Kurai, Keiichiro Takasuna, Hiroshi Yamamoto, Tomonori Koizumi, Takayuki Honda, Keishi Kubo. (2011) Different efficacy of CT screening for lung cancer according to histological type: Analysis of Japanese-smoker cases detected using a low-dose CT screen. Lung Cancer 74:3, 433-440
CrossRef11
Marcin Skrzypski, Rafał Dziadziuszko, Jacek Jassem. (2011) MicroRNA in lung cancer diagnostics and treatment. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 717:1-2, 25-31
CrossRef12
Ji Woong Son, Kang Jin Jeong, Woo-Sean Jean, Soon Young Park, Sanghoon Jheon, Hyun Min Cho, Chang Gyo Park, Hoi Young Lee, Jaeku Kang. (2011) Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients. Cancer Letters 311:1, 29-37
CrossRef13
J.-C. Dalphin. (2011) Quels sont les objectifs du suivi post-professionnel, les bénéfices attendus et les risques possibles ? Objectifs médicaux en termes de morbidité, mortalité et qualité de vie. Revue des Maladies Respiratoires 28:10, 1230-1240
CrossRef14
Ryoichi Kondo, Kazuo Yoshida, Satoshi Kawakami, Takayuki Shiina, Makoto Kurai, Keiichiro Takasuna, Hiroshi Yamamoto, Tomonori Koizumi, Takayuki Honda, Keishi Kubo. (2011) Efficacy of CT screening for lung cancer in never-smokers: Analysis of Japanese cases detected using a low-dose CT screen. Lung Cancer 74:3, 426-432
CrossRef15
Simon L Duke, Tim Eisen. (2011) Finding needles in a haystack: annual low-dose computed tomography screening reduces lung cancer mortality in a high-risk group. Expert Review of Anticancer Therapy 11:12, 1833-1836
CrossRef16
Ray S. Lin, Sylvia K. Plevritis. (2011) Comparing the benefits of screening for breast cancer and lung cancer using a novel natural history model. Cancer Causes & Control
CrossRef17
J. D. Schoenfeld, P. M. Mauch, P. Das, B. Silver, K. J. Marcus, M. A. Stevenson, A. K. Ng. (2011) Lung malignancies after Hodgkin lymphoma: disease characteristics, detection methods and clinical outcome. Annals of Oncology
CrossRef18
Laurie L. Carr, James H. Finigan, Jeffrey A. Kern. (2011) Evaluation and Treatment of Patients with Non–Small Cell Lung Cancer. Medical Clinics of North America 95:6, 1041-1054
CrossRef19
Peter Goldstraw, David Ball, James R Jett, Thierry Le Chevalier, Eric Lim, Andrew G Nicholson, Frances A Shepherd. (2011) Non-small-cell lung cancer. The Lancet 378:9804, 1727-1740
CrossRef20
Claudia I. Henschke, David F. Yankelevitz, Anthony P. Reeves, Matthew D. Cham. (2011) Image Analysis of Small Pulmonary Nodules Identified by Computed Tomography. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 78:6, 882-893
CrossRef21
Nicolaus Andratschke, Frank Zimmermann, Eva Boehm, Sabine Schill, Christine Schoenknecht, Reinhard Thamm, Michael Molls, Carsten Nieder, Hans Geinitz. (2011) Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: Patterns of failure. Radiotherapy and Oncology 101:2, 245-249
CrossRef22
ROBERT P. YOUNG, RAEWYN J. HOPKINS. (2011) How the genetics of lung cancer may overlap with COPD. Respirology 16:7, 1047-1055
CrossRef23
Idan Steinberg, Moshe Ben-David, Israel Gannot. (2011) A new method for tumor detection using induced acoustic waves from tagged magnetic nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine
CrossRef24
A.-B. Cortot. (2011) Vers un dépistage du cancer bronchique par tomodensitométrie ?. Revue des Maladies Respiratoires Actualités 3:5, 512-514
CrossRef25
Brendon M. Stiles, Farooq Mirza, Christopher W. Towe, Vanessa P. Ho, Jeffrey L. Port, Paul C. Lee, Subroto Paul, David F. Yankelevitz, Nasser K. Altorki. (2011) Cumulative Radiation Dose From Medical Imaging Procedures in Patients Undergoing Resection for Lung Cancer. The Annals of Thoracic Surgery 92:4, 1170-1179
CrossRef26
Maria Gonzalez, Jean-Michel Vignaud, Christelle Clement-Duchene, Amandine Luc, Pascal Wild, Odile Bertrand, Luc Thiberville, Yves Martinet, Jacques Benichou, Christophe Paris. (2011) Smoking, Occupational Risk Factors, and Bronchial Tumor Location. Journal of Thoracic Oncology1
CrossRef27
C. Desmetz, A. Mange, T. Maudelonde, J. Solassol. (2011) Autoantibody signatures: progress and perspectives for early cancer detection. Journal of Cellular and Molecular Medicine 15:10, 2013-2024
CrossRef28
Brendon M. Stiles, Nasser K. Altorki. (2011) Screening for Lung Cancer: Challenges for the Thoracic Surgeon. Surgical Oncology Clinics of North America 20:4, 619-635
CrossRef29
Wen Gao, Jing Xu, Yong-qian Shu. (2011) miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer. Expert Review of Respiratory Medicine 5:5, 699-709
CrossRef30
M. Casella, F. Perna, G. Pontone, A. Dello Russo, D. Andreini, G. Pelargonio, S. Riva, G. Fassini, M. Pepi, G. Ballerini, M. Moltrasio, B. Majocchi, S. Bartoletti, A. Formenti, P. Santangeli, L. Di Biase, A. Natale, C. Tondo. (2011) Prevalence and clinical significance of collateral findings detected by chest computed tomography in patients undergoing atrial fibrillation ablation. Europace
CrossRef31
John M. Varlotto, Abram Recht, John C. Flickinger, Laura N. Medford-Davis, Anne-Marie Dyer, Malcolm M. DeCamp. (2011) Lobectomy leads to optimal survival in early-stage small cell lung cancer: A retrospective analysis. The Journal of Thoracic and Cardiovascular Surgery 142:3, 538-546
CrossRef32
Rob J. van Klaveren. (2011) Lung cancer screening. European Journal of Cancer 47, S147-S155
CrossRef33
Irene Cherni, Glen J Weiss. (2011) miRNAs in lung cancer: large roles for small players. Future Oncology 7:9, 1045-1055
CrossRef34
Maddalena Barba, Armando Felsani, Massimo Rinaldi, Salvatore Giunta, Walter Malorni, Marco G. Paggi. (2011) Reducing the risk of overdiagnosis in lung cancer: A support from molecular biology. Journal of Cellular Physiology 226:9, 2213-2214
CrossRef35
Shusuke Sone, Takaomi Hanaoka, Hiroyuki Ogata, Fumiyoshi Takayama, Tomofumi Watanabe, Masayuki Haniuda, Kazuhiko Kaneko, Ryoichi Kondo, Kazuo Yoshida, Takayuki Honda. (2011) Small peripheral lung carcinomas with five-year post-surgical follow-up: assessment by semi-automated volumetric measurement of tumour size, CT value and growth rate on TSCT. European Radiology
CrossRef36
Fabrizio Bianchi, Francesco Nicassio, Matteo Marzi, Elena Belloni, Valentina Dall'Olio, Loris Bernard, Giuseppe Pelosi, Patrick Maisonneuve, Giulia Veronesi, Pier Paolo Di Fiore. (2011) A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Molecular Medicine 3:8, 495-503
CrossRef37
Takeshi Nawa, Tohru Nakagawa, Tetsuya Mizoue, Suzushi Kusano, Tatsuya Chonan, Shimao Fukai, Katsuyuki Endo. (2011) Long-term prognosis of patients with lung cancer detected on low-dose chest computed tomography screening. Lung Cancer
CrossRef38
Samuel Bral, Thierry Gevaert, Nadine Linthout, Harijati Versmessen, Christine Collen, Benedikt Engels, Douwe Verdries, Hendrik Everaert, Nicolas Christian, Mark De Ridder, Guy Storme. (2011) Prospective, Risk-Adapted Strategy of Stereotactic Body Radiotherapy for Early-Stage Non–Small-Cell Lung Cancer: Results of a Phase II Trial. International Journal of Radiation Oncology*Biology*Physics 80:5, 1343-1349
CrossRef39
Xueguo Liu, Mingzhu Liang, Yong Wang, Kai Chen, Xiangmeng Chen, Peixin Qin, Jianxing He, Xianping Yi. (2011) The outcome differences of CT screening for lung cancer pre and post following an algorithm in Zhuhai, China. Lung Cancer 73:2, 230-236
CrossRef40
Chia-Chi Chien, Guilin Zhang, Y. Hwu, Ping Liu, Weisheng Yue, Jianqi Sun, Yan Li, Hongjie Xue, Lisa X. Xu, Chang Hai Wang, Nanyow Chen, Chien Hung Lu, Ting-Kuo Lee, Yuh-Cheng Yang, Yen-Ta Lu, Yu-Tai Ching, T. F. Shih, P. C. Yang, J. H. Je, G. Margaritondo. (2011) Detecting small lung tumors in mouse models by refractive-index microradiology. Analytical and Bioanalytical Chemistry 401:3, 827-835
CrossRef41
S. R. Pine, L. E. Mechanic, L. Enewold, A. K. Chaturvedi, H. A. Katki, Y.-L. Zheng, E. D. Bowman, E. A. Engels, N. E. Caporaso, C. C. Harris. (2011) Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung Cancer. JNCI Journal of the National Cancer Institute 103:14, 1112-1122
CrossRef42
Niccolò Camarlinghi, Ilaria Gori, Alessandra Retico, Roberto Bellotti, Paolo Bosco, Piergiorgio Cerello, Gianfranco Gargano, Ernesto Lopez Torres, Rosario Megna, Marco Peccarisi, Maria Evelina Fantacci. (2011) Combination of computer-aided detection algorithms for automatic lung nodule identification. International Journal of Computer Assisted Radiology and Surgery
CrossRef43
P. B. Bach. (2011) Inconsistencies in Findings From the Early Lung Cancer Action Project Studies of Lung Cancer Screening. JNCI Journal of the National Cancer Institute 103:13, 1002-1006
CrossRef44
Martin Schramm, Christian Wrobel, Ingmar Born, Marietta Kazimirek, Natalia Pomjanski, Marina William, Rainer Kappes, Claus Dieter Gerharz, Stefan Biesterfeld, Alfred Böcking. (2011) Equivocal cytology in lung cancer diagnosis. Cancer Cytopathology 119:3, 177-192
CrossRef45
Millennia Foy, Rowena Yip, Xing Chen, Marek Kimmel, Olga Y. Gorlova, Claudia I. Henschke. (2011) Modeling the mortality reduction due to computed tomography screening for lung cancer. Cancer 117:12, 2703-2708
CrossRef46
Caroline Desmetz, Jérôme Lacombe, Alain Mange, Thierry Maudelonde, Jérôme Solassol. (2011) Autoanticorps et diagnostic précoce des cancers. médecine/sciences 27:6-7, 633-638
CrossRef47
Saburo Takata, Nagio Takigawa, Yoshihiko Segawa, Toshio Kubo, Kadoaki Ohashi, Toshiyuki Kozuki, Norihiro Teramoto, Motohiro Yamashita, Shinichi Toyooka, Mitsune Tanimoto, Katsuyuki Kiura. (2011) STAT3 expression in activating EGFR-driven adenocarcinoma of the lung. Lung Cancer
CrossRef48
William Moore, Jennifer Ripton-Snyder, George Wu, Craig Hendler. (2011) Sensitivity and Specificity of a CAD Solution for Lung Nodule Detection on Chest Radiograph with CTA Correlation. Journal of Digital Imaging 24:3, 405-410
CrossRef49
Jerome Solassol, Thierry Maudelonde, Alain Mange, Jean-Louis Pujol. (2011) Clinical Relevance of Autoantibody Detection in Lung Cancer. Journal of Thoracic Oncology 6:5, 955-962
CrossRef50
Sinead Cuffe, Teng Moua, Ruth Summerfield, Heidi Roberts, James Jett, Frances A. Shepherd. (2011) Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy Smokers. Journal of Thoracic Oncology 6:4, 818-822
CrossRef51
Claudia I. Henschke, Paolo Boffetta, Olga Gorlova, Rowena Yip, John O. DeLancey, Millennia Foy. (2011) Assessment of lung-cancer mortality reduction from CT Screening. Lung Cancer 71:3, 328-332
CrossRef52
Giulia Veronesi, Patrick Maisonneuve, Giuseppe Pelosi, Monica Casiraghi, Bernardo G. Agoglia, Alessandro Borri, Laura L. Travaini, Massimo Bellomi, Cristiano Rampinelli, Daniela Brambilla, Raffaella Bertolotti, Lorenzo Spaggiari. (2011) Screening-Detected Lung Cancers. Journal of Thoracic Oncology 6:3, 525-530
CrossRef53
Y.-H. Li, S.-H. Shieh, C.-Y. Chen. (2011) The Influence of Health Behaviors on Survival in Lung Cancer Patients in Taiwan. Japanese Journal of Clinical Oncology 41:3, 365-372
CrossRef54
Anton Amann, Massimo Corradi, Peter Mazzone, Antonio Mutti. (2011) Lung cancer biomarkers in exhaled breath. Expert Review of Molecular Diagnostics 11:2, 207-217
CrossRef55
Maurizio Infante, Giuseppe Chiesa, Daniel Solomon, Emanuela Morenghi, Eliseo Passera, Fabio Romano Lutman, Edoardo Bottoni, Umberto Cariboni, Valentina Errico, Emanuele Voulaz, Giorgio Ferraroli, Alberto Testori, Francesco Inzirillo, Maurizio Chiarenza, Massimo Roncalli, Silvio Cavuto, Arturo Chiti, Marco Alloisio, Gianluigi Ravasi. (2011) Surgical Procedures in the DANTE Trial, A Randomized Study of Lung Cancer Early Detection with Spiral Computed Tomography. Journal of Thoracic Oncology 6:2, 327-335
CrossRef56
William D. Travis, Elisabeth Brambilla, Masayuki Noguchi, Andrew G. Nicholson, Kim R. Geisinger, Yasushi Yatabe, David G. Beer, Charles A. Powell, Gregory J. Riely, Paul E. Van Schil, Kavita Garg, John H. M. Austin, Hisao Asamura, Valerie W. Rusch, Fred R. Hirsch, Giorgio Scagliotti, Tetsuya Mitsudomi, Rudolf M. Huber, Yuichi Ishikawa, James Jett, Montserrat Sanchez-Cespedes, Jean-Paul Sculier, Takashi Takahashi, Masahiro Tsuboi, Johan Vansteenkiste, Ignacio Wistuba, Pan-Chyr Yang, Denise Aberle, Christian Brambilla, Douglas Flieder, Wilbur Franklin, Adi Gazdar, Michael Gould, Philip Hasleton, Douglas Henderson, Bruce Johnson, David Johnson, Keith Kerr, Keiko Kuriyama, Jin Soo Lee, Vincent A. Miller, Iver Petersen, Victor Roggli, Rafael Rosell, Nagahiro Saijo, Erik Thunnissen, Ming Tsao, David Yankelewitz. (2011) International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. Journal of Thoracic Oncology 6:2, 244-285
CrossRef57
Robert A. Smith, Vilma Cokkinides, Durado Brooks, Debbie Saslow, Mona Shah, Otis W. Brawley. (2011) Cancer screening in the United States, 2011. CA: A Cancer Journal for Clinicians 61:1, 8-30
CrossRef58
Meleeneh Kazarian, Ite A Laird-Offringa. (2011) Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Molecular Cancer 10:1, 33
CrossRef59
Alessandro Riccardi, Todor Sergueev Petkov, Gianluca Ferri, Matteo Masotti, Renato Campanini. (2011) Computer-aided detection of lung nodules via 3D fast radial transform, scale space representation, and Zernike MIP classification. Medical Physics 38:4, 1962
CrossRef60
Liang Gao, Fuhai Li, Michael J. Thrall, Yaliang Yang, Jiong Xing, Ahmad A. Hammoudi, Hong Zhao, Yehia Massoud, Philip T. Cagle, Yubo Fan, Kelvin K. Wong, Zhiyong Wang, Stephen T. C. Wong. (2011) On-the-spot lung cancer differential diagnosis by label-free, molecular vibrational imaging and knowledge-based classification. Journal of Biomedical Optics 16:9, 096004
CrossRef61
Xi Chen, Zhibin Hu, Wenjing Wang, Yi Ba, Lijia Ma, Chunni Zhang, Cheng Wang, Zhiji Ren, Yang Zhao, Sijia Wu, Rui Zhuang, Yixin Zhang, Heng Hu, Chazhen Liu, Lin Xu, Jun Wang, Hongbing Shen, Junfeng Zhang, Ke Zen, Chen-Yu Zhang. (2011) Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. International Journal of Cancern/a-n/a
CrossRef62
Marco G. Paggi, Rosa Vona, Claudia Abbruzzese, Walter Malorni. (2010) Gender-related disparities in non-small cell lung cancer. Cancer Letters 298:1, 1-8
CrossRef63
David S. Yoo, Terence Z. Wong, David M. Brizel. (2010) The Role of Adaptive and Functional Imaging Modalities in Radiation Therapy: Approach and Application from a Radiation Oncology Perspective. Seminars in Ultrasound, CT, and MRI 31:6, 444-461
CrossRef64
, D. R. Aberle, A. M. Adams, C. D. Berg, J. D. Clapp, K. L. Clingan, I. F. Gareen, D. A. Lynch, P. M. Marcus, P. F. Pinsky. (2010) Baseline Characteristics of Participants in the Randomized National Lung Screening Trial. JNCI Journal of the National Cancer Institute 102:23, 1771-1779
CrossRef65
Paul Maddison, Alison Thorpe, Paul Silcocks, John F.R. Robertson, Caroline J. Chapman. (2010) Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer. Lung Cancer 70:3, 335-339
CrossRef66
Suzushi Kusano, Toru Nakagawa, Takatoshi Aoki, Takeshi Nawa, Kuniyoshi Nakashima, Yoshihiro Goto, Yukunori Korogi. (2010) Efficacy of computer-aided diagnosis in lung cancer screening with low-dose spiral computed tomography: receiver operating characteristic analysis of radiologists’ performance. Japanese Journal of Radiology 28:9, 649-655
CrossRef67
Chad G. Ball, Camilo Correa-Gallego, Thomas J. Howard, Nicholas J. Zyromski, Michael G. House, Henry A. Pitt, Atilla Nakeeb, Christian M. Schmidt, Fatih Akisik, Keith D. Lillemoe. (2010) Radiation Dose from Computed Tomography in Patients with Necrotizing Pancreatitis: How Much Is Too Much?. Journal of Gastrointestinal Surgery 14:10, 1529-1535
CrossRef68
A. Amann, M. Ligor, T. Ligor, A. Bajtarevic, C. Ager, M. Pienz, H. Denz, M. Fiegl, W. Hilbe, W. Weiss, P. Lukas, H. Jamnig, M. Hackl, A. Haidenberger, A. Sponring, W. Filipiak, W. Miekisch, J. Schubert, J. Troppmair, B. Buszewski. (2010) Analysis of exhaled breath for screening of lung cancer patients. memo - Magazine of European Medical Oncology 3:3, 106-112
CrossRef69
Nicholas R. Thiessen, Ross Bremner. (2010) The Solitary Pulmonary Nodule: Approach for a General Surgeon. Surgical Clinics of North America 90:5, 1003-1018
CrossRef70
Mizuki Ikehara, Haruhiro Saito, Tetsuro Kondo, Shuji Murakami, Hiroyuki Ito, Masahiro Tsuboi, Fumihiro Oshita, Kazumasa Noda, Haruhiko Nakayama, Tomoyuki Yokose, Yoichi Kameda, Kouzo Yamada. (2010) Comparison of thin-section CT and pathological findings in small solid-density type pulmonary adenocarcinoma: Prognostic factors from CT findings. European Journal of Radiology
CrossRef71
Romane M. Schook, Berber B. M. Postmus, Remco M. van den Berg, Thomas G. Sutedja, Frances S. Man de, Egbert F. Smit, Pieter E. Postmus. (2010) The Finding of Premalignant Lesions is Not Associated with Smoking Cessation in Chemoprevention Study Volunteers. Journal of Thoracic Oncology 5:8, 1240-1245
CrossRef72
Peter J. Mazzone. (2010) Lung Cancer Screening: An Update, Discussion, and Look Ahead. Current Oncology Reports 12:4, 226-234
CrossRef73
Giulia Veronesi, Domenico Galetta, Patrick Maisonneuve, Franca Melfi, Ralph Alexander Schmid, Alessandro Borri, Fernando Vannucci, Lorenzo Spaggiari. (2010) Four-arm robotic lobectomy for the treatment of early-stage lung cancer. The Journal of Thoracic and Cardiovascular Surgery 140:1, 19-25
CrossRef74
Maurizio V Infante, Jesper H Pedersen. (2010) Screening for lung cancer: are we there yet?. Current Opinion in Pulmonary Medicine 16:4, 301-306
CrossRef75
A. Sancini, M. Fioravanti, M. Ciarrocca, P. Palermo, M. Fiaschetti, M.P. Schifano, G. Tomei, F. Tomei. (2010) Pulmonary nodules in workers exposed to urban stressor. Environmental Research 110:5, 519-525
CrossRef76
U Pastorino. (2010) Lung cancer screening. British Journal of Cancer 102:12, 1681-1686
CrossRef77
Axel Goßmann. (2010) Bronchialkarzinom – Früherkennung. Onkopipeline 3:2, 94-98
CrossRef78
Barbara K. Dunn, Peter Greenwald. (2010) Cancer Prevention I: Introduction. Seminars in Oncology 37:3, 190-201
CrossRef79
H. G. Welch, W. C. Black. (2010) Overdiagnosis in Cancer. JNCI Journal of the National Cancer Institute 102:9, 605-613
CrossRef80
Hatim Fakir, Werner Hofmann, Rainer K. Sachs. (2010) Modeling progression in radiation-induced lung adenocarcinomas. Radiation and Environmental Biophysics 49:2, 169-176
CrossRef81
Francesca Maria Carozzi, Simonetta Bisanzi, Patrizia Falini, Cristina Sani, Giulia Venturini, Andrea Lopes Pegna, Roberto Bianchi, Cristina Ronchi, Giulia Picozzi, Mario Mascalchi, Laura Carrozzi, Filomena Baliva, Francesco Pistelli, Laura Tavanti, Fabio Falaschi, Michela Grazzini, Florio Innocenti, Eugenio Paci. (2010) Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis. Lung Cancer 68:2, 216-221
CrossRef82
Matthew Blum, Alberto de Hoyos. (2010) Surgical Approach to the Small Detected Lung Nodule. Clinical Pulmonary Medicine 17:3, 129-135
CrossRef83
Ted Way, Heang-Ping Chan, Lubomir Hadjiiski, Berkman Sahiner, Aamer Chughtai, Thomas K. Song, Chad Poopat, Jadranka Stojanovska, Luba Frank, Anil Attili, Naama Bogot, Philip N. Cascade, Ella A. Kazerooni. (2010) Computer-Aided Diagnosis of Lung Nodules on CT Scans:. Academic Radiology 17:3, 323-332
CrossRef84
Hikmet Yorgun, Ergün Barş Kaya, Tuncay Hazirolan, Ahmet Hakan Ateş, Uğur Canpolat, Hamza Sunman, Kudret Aytemr, Giray Kabakçi, Lale Tokgözoğlu, Muşturay Karçaaltincaba, Deniz Akata, Ali Oto. (2010) Prevalence of Incidental Pulmonary Findings and Early Follow-Up Results in Patients Undergoing Dual-Source 64-Slice Computed Tomography Coronary Angiography. Journal of Computer Assisted Tomography 34:2, 296-301
CrossRef85
Nobuhiko Seki, Kenji Eguchi, Masahiro Kaneko, Hironobu Ohmatsu, Ryutaro Kakinuma, Eisuke Matsui, Masahiko Kusumoto, Takaaki Tsuchida, Hiroyuki Nishiyama, Noriyuki Moriyama. (2010) The adenocarcinoma-specific stage shift in the Anti-lung Cancer Association project: Significance of repeated screening for lung cancer for more than 5 years with low-dose helical computed tomography in a high-risk cohort. Lung Cancer 67:3, 318-324
CrossRef86
T.D. Soper, D.R. Haynor, R.W. Glenny, E.J. Seibel. (2010)
In Vivo Validation of a Hybrid Tracking System for Navigation of an Ultrathin Bronchoscope Within Peripheral Airways. IEEE Transactions on Biomedical Engineering 57:3, 736-745
CrossRef87
Takayuki Fukui, Tetsuya Mitsudomi. (2010) Small peripheral lung adenocarcinoma: Clinicopathological features and surgical treatment. Surgery Today 40:3, 191-198
CrossRef88
A W Castleberry, F W Grannis. (2010) What is a reasonable cost to refute a preposterous hypothesis?. British Journal of Cancer 102:3, 627-628
CrossRef89
Stefano Bartoletti, Francesco Perna, Pasquale Santangeli, Michela Casella. (2010) A Closer Look at Incidental Findings on Cardiac Computed Tomography. Journal of the American College of Cardiology 55:7, 702-703
CrossRef90
Eiran Warner, Alan Jotkowitz, Nimrod Maimon. (2010) Lung cancer screening – are we there yet?. European Journal of Internal Medicine 21:1, 6-11
CrossRef91
Sara W. Goldberg, James L. Mulshine, Dale Hagstrom, Bruce S. Pyenson. (2010) An Actuarial Approach to Comparing Early Stage and Late Stage Lung Cancer Mortality and Survival. Population Health Management 13:1, 33-46
CrossRef92
Ravi J. Menezes, Heidi C. Roberts, Narinder S. Paul, Maureen McGregor, Tae Bong Chung, Demetris Patsios, Gordon Weisbrod, Stephen Herman, Andre Pereira, Alexander McGregor, Zhi Dong, Igor Sitartchouk, Scott Boerner, Ming-Sound Tsao, Shaf Keshavjee, Frances A. Shepherd. (2010) Lung cancer screening using low-dose computed tomography in at-risk individuals: The Toronto experience. Lung Cancer 67:2, 177-183
CrossRef93
Michael V. Huppmann, William B. Johnson, Marcia C. Javitt. (2010) Radiation Risks from Exposure to Chest Computed Tomography. Seminars in Ultrasound, CT, and MRI 31:1, 14-28
CrossRef94
K A M van den Bergh, M L Essink-Bot, G J J M Borsboom, E Th Scholten, M Prokop, H J de Koning, R J van Klaveren. (2010) Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). British Journal of Cancer 102:1, 27-34
CrossRef95
G. Bastarrika, A. Alonso, R. Saiz-Mendiguren, J. Arias, O. Cosín. (2010) Coronary artery calcium quantification with non-ECG-gated low-dose CT of the chest. Radiología (English Edition) 52:1, 30-36
CrossRef96
O. Molinier, C. Dehe, F. Goupil, P. Lemeunier-Lelievre, A. Paris, F.-X. Lebas. (2010) Nodulo polmonare solitario. EMC - AKOS - Trattato di Medicina 12:2, 1-9
CrossRef97
Scott Swanson. (2010) Invited Commentary. The Annals of Thoracic Surgery 89:1, 218-219
CrossRef98
G. Bastarrika, A. Alonso, R. Saiz-Mendiguren, J. Arias, O. Cosín. (2010) Cuantificación de la calcificación coronaria en tomografía computarizada torácica de baja dosis de radiación sin sincronización cardiaca. Radiología 52:1, 30-36
CrossRef99
Edith M. Marom. 2010. Imaging Tumors of the Lung and Pleura. , 1-40.
CrossRef100
Ke Zen, Chen-Yu Zhang. (2010) Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Medicinal Research Reviewsn/a-n/a
CrossRef101
Brian Tzung, Peter J. Julien. 2010. Lung Cancer Screening. , 197-200.
CrossRef102
Shusuke Sone, Toru Matsumoto, Takayuki Honda, Kenji Tsushima, Fumiyoshi Takayama, Takaomi Hanaoka, Ryoichi Kondo, Masayuki Haniuda. (2010) HRCT Features of Small Peripheral Lung Carcinomas Detected in a Low-dose CT Screening Program. Academic Radiology 17:1, 75-83
CrossRef103
Michael J. Liptay, Sanjib Basu, Michael C. Hoaglin, Neil Freedman, L. Penfield Faber, William H. Warren, Zane T. Hammoud, Anthony W. Kim. (2009) Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer. Journal of Surgical Oncology 100:8, 703-707
CrossRef104
van Klaveren, Rob J., Oudkerk, Matthijs, Prokop, Mathias, Scholten, Ernst T., Nackaerts, Kristiaan, Vernhout, Rene, van Iersel, Carola A., van den Bergh, Karien A.M., van 't Westeinde, Susan, van der Aalst, Carlijn, Thunnissen, Erik, Xu, Dong Ming, Wang, Ying, Zhao, Yingru, Gietema, Hester A., de Hoop, Bart-Jan, Groen, Harry J.M., de Bock, Geertruida H., van Ooijen, Peter, Weenink, Carla, Verschakelen, Johny, Lammers, Jan-Willem J., Timens, Wim, Willebrand, Dik, Vink, Aryan, Mali, Willem, de Koning, Harry J., . (2009) Management of Lung Nodules Detected by Volume CT Scanning. New England Journal of Medicine 361:23, 2221-2229
Full Text105
Berkman Sahiner, Heang-Ping Chan, Lubomir M. Hadjiiski, Philip N. Cascade, Ella A. Kazerooni, Aamer R. Chughtai, Chad Poopat, Thomas Song, Luba Frank, Jadranka Stojanovska, Anil Attili. (2009) Effect of CAD on Radiologists' Detection of Lung Nodules on Thoracic CT Scans: Analysis of an Observer Performance Study by Nodule Size. Academic Radiology 16:12, 1518-1530
CrossRef106
Masatoshi Kakihana, Tatsuo Ohira, Daniel Chan, Robin B. Webster, Harubumi Kato, Harry A. Drabkin, Robert M. Gemmill. (2009) Induction of E-Cadherin in Lung Cancer and Interaction with Growth Suppression by Histone Deacetylase Inhibition. Journal of Thoracic Oncology 4:12, 1455-1465
CrossRef107
G.M.F. Wallace, J.H. Winter, J.E. Winter, A. Taylor, T.W. Taylor, R.C. Cameron. (2009) Chest X-rays in COPD screening: Are they worthwhile?. Respiratory Medicine 103:12, 1862-1865
CrossRef108
Noriyasu Homma, Yuko Kawai, Satoshi Shimoyama, Tadashi Ishibashi, Makoto Yoshizawa. (2009) A study on the effect of morphological filters on computer-aided medical image diagnosis. Artificial Life and Robotics 14:2, 191-194
CrossRef109
James T. Dobbins, H. Page McAdams. (2009) Chest tomosynthesis: Technical principles and clinical update. European Journal of Radiology 72:2, 244-251
CrossRef110
Jeremy J. Erasmus. (2009) Fluorodeoxyglucose Uptake Predicts Survival in a CT Screening Trial. Journal of Thoracic Oncology 4:11, 1305-1306
CrossRef111
Maksim A. Pashkevich, Bronislava M. Sigal, Sylvia K. Plevritis. (2009) Modeling the transition of lung cancer from early to advanced stage. Cancer Causes & Control 20:9, 1559-1569
CrossRef112
Ugo Pastorino, Claudio Landoni, Alfonso Marchianò, Elisa Calabrò, Gabriella Sozzi, Rosalba Miceli, Maria Picchio, Luigi Mariani, Cristina Messa, Ferruccio Fazio. (2009) Fluorodeoxyglucose Uptake Measured by Positron Emission Tomography and Standardized Uptake Value Predicts Long-Term Survival of CT Screening Detected Lung Cancer in Heavy Smokers. Journal of Thoracic Oncology 4:11, 1352-1356
CrossRef113
Joel J. Bechtel, William A. Kelley, Teresa A. Coons, Philip Mohler, Andrew Mohler, David James, Thomas L. Petty. (2009) Five-Year Outcome of Lung Cancer Detection in Patients With and Without Airflow Obstruction in a Primary Care Outpatient Practice. Journal of Thoracic Oncology 4:11, 1347-1351
CrossRef114
Jimmy MacHaalany, Yeung Yam, Terrence D. Ruddy, Arun Abraham, Li Chen, Rob S. Beanlands, Benjamin J.W. Chow. (2009) Potential Clinical and Economic Consequences of Noncardiac Incidental Findings on Cardiac Computed Tomography. Journal of the American College of Cardiology 54:16, 1533-1541
CrossRef115
Mark A. Hlatky, Carlos Iribarren. (2009) The Dilemma of Incidental Findings on Cardiac Computed Tomography
Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.. Journal of the American College of Cardiology 54:16, 1542-1543
CrossRef116
Stephen W Duffy, Olaide Y Raji, Olorunsola F Agbaje, Prue C Allgood, Adrian Cassidy, John K Field. (2009) Use of lung cancer risk models in planning research and service programs in CT screening for lung cancer. Expert Review of Anticancer Therapy 9:10, 1467-1472
CrossRef117
Motoyasu Sagawa, Katsuo Usuda, Hirokazu Aikawa, Yuichiro Machida, Makoto Tanaka, Masakatsu Ueno, Tsutomu Sakuma. (2009) Lung cancer screening and its efficacy. General Thoracic and Cardiovascular Surgery 57:10, 519-527
CrossRef118
A W Castleberry, D Smith, C Anderson, A J Rotter, F W Grannis. (2009) Cost of a 5-year lung cancer survivor: symptomatic tumour identification vs proactive computed tomography screening. British Journal of Cancer 101:6, 882-896
CrossRef119
Lauren G. Collins, Daisy T. Wynn, Joshua H. Barash. (2009) The Future of Cancer Screening. Primary Care: Clinics in Office Practice 36:3, 623-639
CrossRef120
Dae-Sung Hyun, Hong-Tae Kim, Sang-Hoon Jheon, Seung-Il Park, Jong-Ki Kim. (2009) A preliminary study of protoporphyrin-IX as a potential candidate for identification of lung cancer cells using fluorescence microscopy. Photodiagnosis and Photodynamic Therapy 6:3-4, 221-226
CrossRef121
David B. Resnik. (2009) Perspective: Disclosing Hidden Sources of Funding. Academic Medicine 84:9, 1226-1228
CrossRef122
Chang-Qi Zhu, Melania Pintilie, Thomas John, Dan Strumpf, Frances A. Shepherd, Sandy D. Der, Igor Jurisica, Ming-Sound Tsao. (2009) Understanding Prognostic Gene Expression Signatures in Lung Cancer. Clinical Lung Cancer 10:5, 331-340
CrossRef123
Justine A. Barletta, Sven Perner, A. John Iafrate, Beow Y. Yeap, Barbara A. Weir, Laura A. Johnson, Bruce E. Johnson, Matthew Meyerson, Mark A. Rubin, William D. Travis, Massimo Loda, Lucian R. Chirieac. (2009) Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma. Journal of Cellular and Molecular Medicine 13:8b, 1977-1986
CrossRef124
Gorka Bastarrika, Juan P. Wisnivesky, Jesús C. Pueyo, Lourdes Díaz, María Arraiza, Alberto Villanueva, Ana B. Alcaide, Arantza Campo, Luis Seijo, Juan P. de Torres, Javier J. Zulueta. (2009) Low-dose Volumetric Computed Tomography for Quantification of Emphysema in Asymptomatic Smokers Participating in an Early Lung Cancer Detection Trial. Journal of Thoracic Imaging 24:3, 206-211
CrossRef125
J. Ignacio Herrero, Felix Alegre, Jorge Quiroga, Fernando Pardo, Mercedes Iñarrairaegui, Bruno Sangro, Fernando Rotellar, Custodia Montiel, Jesus Prieto. (2009) Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report. Clinical Transplantation 23:4, 532-536
CrossRef126
Meredith L. Turetz, Timothy P. O’Connor, Ann E. Tilley, Yael Strulovici-Barel, Jacqueline Salit, David Dang, Matthew Teater, Jason Mezey, Andrew G. Clark, Ronald G. Crystal. (2009) Trachea Epithelium as a “Canary” for Cigarette Smoking-Induced Biologic Phenotype of the Small Airway Epithelium. Clinical and Translational Science 2:4, 260-272
CrossRef127
Andrea Lopes Pegna, Giulia Picozzi. (2009) Lung cancer screening update. Current Opinion in Pulmonary Medicine 15:4, 327-333
CrossRef128
Julio Sánchez De Cos Escuín. (2009) El cáncer de pulmón en España. Epidemiología, supervivencia y tratamiento actuales. Archivos de Bronconeumología 45:7, 341-348
CrossRef129
Yair Lotan, Keren Elias, Robert S. Svatek, Aditya Bagrodia, Geoffrey Nuss, Brett Moran, Arthur I. Sagalowsky. (2009) Bladder Cancer Screening in a High Risk Asymptomatic Population Using a Point of Care Urine Based Protein Tumor Marker. The Journal of Urology 182:1, 52-58
CrossRef130
Lisa R. Shugarman, Katherine Mack, Melony E. S. Sorbero, Haijun Tian, Arvind K. Jain, J Scott Ashwood, Steven M. Asch. (2009) Race and Sex Differences in the Receipt of Timely and Appropriate Lung Cancer Treatment. Medical Care 47:7, 774-781
CrossRef131
Tuula Vierikko, Sirkku Kivistö, Ritva Järvenpää, Jukka Uitti, Panu Oksa, Pauliina Virtema, Tapio Vehmas. (2009) Psychological impact of computed tomography screening for lung cancer and occupational pulmonary disease among asbestos-exposed workers. European Journal of Cancer Prevention 18:3, 203-206
CrossRef132
David E Midthun. (2009) Caution: screening for lung cancer. Expert Review of Respiratory Medicine 3:3, 203-205
CrossRef133
Dong Ming Xu, Rob J. van Klaveren, Geertruida H. de Bock, Anne L.M. Leusveld, Monique D. Dorrius, Yingru Zhao, Ying Wang, Harry J. de Koning, Ernst T. Scholten, Johny Verschakelen, Mathias Prokop, Matthijs Oudkerk. (2009) Role of baseline nodule density and changes in density and nodule features in the discrimination between benign and malignant solid indeterminate pulmonary nodules. European Journal of Radiology 70:3, 492-498
CrossRef134
Sam J. Lehman, Suhny Abbara, Ricardo C. Cury, John T. Nagurney, Joe Hsu, Aashish Goela, Christopher L. Schlett, Jonathan D. Dodd, Thomas J. Brady, Fabian Bamberg, Udo Hoffmann. (2009) Significance of Cardiac Computed Tomography Incidental Findings in Acute Chest Pain. The American Journal of Medicine 122:6, 543-549
CrossRef135
Elyse R. Park, Jamie S. Ostroff, William Rakowski, Ilana F. Gareen, Michael A. Diefenbach, Sandra Feibelmann, Nancy A. Rigotti. (2009) Risk Perceptions Among Participants Undergoing Lung Cancer Screening: Baseline Results from the National Lung Screening Trial. Annals of Behavioral Medicine 37:3, 268-279
CrossRef136
Madeline Vazquez, Darryl Carter, Elizabeth Brambilla, Adi Gazdar, Masayuki Noguchi, William D. Travis, Yao Huang, Lijuan Zhang, Rowena Yip, David F. Yankelevitz, Claudia I. Henschke. (2009) Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: Histopathologic features and their prognostic implications. Lung Cancer 64:2, 148-154
CrossRef137
Adrienne A. Phillips, Jessica E. Justman. (2009) Screening HIV-infected patients for non-AIDS-defining malignancies. Current HIV/AIDS Reports 6:2, 83-92
CrossRef138
Kwang-Ho In, Yong-Soo Kwon, In-Jae Oh, Kyu-Sik Kim, Maan-Hong Jung, Kwan-Ho Lee, Sun-Young Kim, Jeong-Seon Ryu, Sung-Yong Lee, Eun-Taik Jeong, Sang-Yeub Lee, Ho-Kee Yum, Chang-Geol Lee, Woo-Sung Kim, Jae-Ill Zo, Hojoong Kim, Young-Whan Kim, Se-Kyu Kim, Jae-Cheol Lee, Young-Chul Kim. (2009) Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: A Korean Lung Cancer Registry Study. Lung Cancer 64:2, 232-237
CrossRef139
Heidi C. Roberts, Demetris A. Patsios, Narinder S. Paul, Marc dePerrot, Warren Teel, Hamid Bayanati, Frances Shepherd, Michael R. Johnston. (2009) Screening for Malignant Pleural Mesothelioma and Lung Cancer in Individuals with a History of Asbestos Exposure. Journal of Thoracic Oncology 4:5, 620-628
CrossRef140
Riken Kawachi, Shun-ichi Watanabe, Hisao Asamura. (2009) Clinicopathological Characteristics of Screen-Detected Lung Cancers. Journal of Thoracic Oncology 4:5, 615-619
CrossRef141
E. Granell, A. Hidalgo, A. Martínez, I. Gich, I. Bolívar, T. Franquet, A. Giménez, T. Alepuz. (2009) Evaluación del programa de diagnóstico y tratamiento rápido del cáncer de pulmón. Radiología 51:3, 294-299
CrossRef142
Hisamitsu OMORI, Mayumi TSUJI, Keiko SATA, Cieko IYONAGA, Akiko NARIMATSU, Shuichi MIHARA, Tohru MARUBAYASHI, Seiji TOMIGUCHI, Hiroaki NOMORI, Hirotsugu KOHROGI, Takahiko KATOH. (2009) Correlation of C-reactive protein with disease severity in CT diagnosed emphysema. Respirology 14:4, 551-558
CrossRef143
Matthew Freedman, Esther H. Chang, Qi Zhou, Kathleen F. Pirollo. (2009) Nanodelivery of MRI Contrast Agent Enhances Sensitivity of Detection of Lung Cancer Metastases. Academic Radiology 16:5, 627-637
CrossRef144
Jesper H. Pedersen, Haseem Ashraf, Asger Dirksen, Karen Bach, Hanne Hansen, Phillip Toennesen, Hanne Thorsen, John Brodersen, Birgit Guldhammer Skov, Martin Døssing, Jann Mortensen, Klaus Richter, Paul Clementsen, Niels Seersholm. (2009) The Danish Randomized Lung Cancer CT Screening Trial—Overall Design and Results of the Prevalence Round. Journal of Thoracic Oncology 4:5, 608-614
CrossRef145
Kris Nackaerts, Johan Vansteenkiste. (2009) Low-Dose CT Screening for Lung Cancer: Trial and Error?. Journal of Thoracic Oncology 4:5, 563-564
CrossRef146
Arturo H. Huerta, Ramon M. Marrades, Antoni Torres. (2009) A Clinical Pathway for Diagnosing and Staging Lung Cancer. Clinical Pulmonary Medicine 16:3, 150-156
CrossRef147
Ingrid M. Burger, Nancy E. Kass. (2009) Screening in the Dark: Ethical Considerations of Providing Screening Tests to Individuals When Evidence is Insufficient to Support Screening Populations. The American Journal of Bioethics 9:4, 3-14
CrossRef148
Fotis Vlastos, Stéphanie Lacomme, Pascal Wild, Stéphane Poulain, Joëlle Siat, Gilles Grosdidier, Stanislas du Manoir, Ben Monga, Georgios Hillas, Roselyne Varsovie, Frédérique Claudot, Béatrice Marie, Jean Michel Vignaud, Nadine Szymanski. (2009) Do Evolving Practices Improve Survival in Operated Lung Cancer Patients? A Biobank May Answer. Journal of Thoracic Oncology 4:4, 505-511
CrossRef149
Andrea Lopes Pegna, Giulia Picozzi, Mario Mascalchi, Francesca Maria Carozzi, Laura Carrozzi, Camilla Comin, Cheti Spinelli, Fabio Falaschi, Michela Grazzini, Florio Innocenti, Cristina Ronchi, Eugenio Paci. (2009) Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 64:1, 34-40
CrossRef150
Marius Staring, Josien P. W. Pluim, Bartjan de Hoop, Stefan Klein, Bram van Ginneken, Hester Gietema, George Nossent, Cornelia Schaefer-Prokop, Saskia van de Vorst, Mathias Prokop. (2009) Image Subtraction Facilitates Assessment of Volume and Density Change in Ground-Glass Opacities in Chest CT. Investigative Radiology 44:2, 61-66
CrossRef151
I. Villamil Cajoto, J.M. García Prim, F.J. González Barcala, A. Pose Reino, S. Paredes Vila, U. Calvo Álvarez, L. Valdés Cuadrado. (2009) Motivo de consulta en el diagnóstico de cáncer de pulmón. Revisión de 481 casos. Revista Clínica Española 209:2, 67-72
CrossRef152
Pascal Uehlinger, Tanja Gabrecht, Thomas Glanzmann, Jean-Pierre Ballini, Alexandre Radu, Snezana Andrejevic, Philippe Monnier, Georges Wagnières. (2009) In vivo time-resolved spectroscopy of the human bronchial early cancer autofluorescence. Journal of Biomedical Optics 14:2, 024011
CrossRef153
Ted W. Way, Berkman Sahiner, Heang-Ping Chan, Lubomir Hadjiiski, Philip N. Cascade, Aamer Chughtai, Naama Bogot, Ella Kazerooni. (2009) Computer-aided diagnosis of pulmonary nodules on CT scans: Improvement of classification performance with nodule surface features. Medical Physics 36:7, 3086
CrossRef154
Michael Hsie, Stefania Morbidini-Gaffney, Leslie J. Kohman, Elisabeth Dexter, Ernest M. Scalzetti, Jeffrey A. Bogart. (2009) Definitive Treatment of Poor-Risk Patients with Stage I Lung Cancer. Journal of Thoracic Oncology 4:1, 69-73
CrossRef155
Claudia I. Henschke, Rowena Yip, David F. Yankelevitz. (2009) CT Screening for Lung Cancer: Update 2008. Haigan 49:4, 477-490
CrossRef156
Giuseppe Bruschi, Serena Conforti, Massimo Torre, Tiziano Colombo, Claudio F. Russo, Giovanna Pedrazzini, Maria Frigerio, Mario Ravini. (2009) Long-term results of lung cancer after heart transplantation: Single center 20-year experience. Lung Cancer 63:1, 146-150
CrossRef157
Young-Soon Yoon, Chang-Hoon Lee, Young-Ae Kang, Sung-Youn Kwon, Ho Il Yoon, Jae-Ho Lee, Choon-Taek Lee. (2009) Impact of Toxocariasis in Patients with Unexplained Patchy Pulmonary Infiltrate in Korea. Journal of Korean Medical Science 24:1, 40
CrossRef158
Thomas Neumann, Michael Meyer, Florence W. Patten, Fred L. Johnson, Yener S. Erozan, William J. Frable, Prabodh K. Gupta, Muhammad B. Zaman, Alan C. Nelson. (2009) Premalignant and malignant cells in sputum from lung cancer patients. Cancer CytopathologyNA-NA
CrossRef159
James T. Dobbins. (2009) Tomosynthesis imaging: At a translational crossroads. Medical Physics 36:6, 1956
CrossRef160
Nirmal K. Veeramachaneni, Traves D. Crabtree, Daniel Kreisel, Jennifer B. Zoole, Joanne F. Musick, Nicole G. Taylor, Alexander S. Krupnick, David S. Gierada, G. Alexander Patterson, Bryan F. Meyers. (2009) A thoracic surgery clinic dedicated to indeterminate pulmonary nodules: Too many scans and too little pathology?. The Journal of Thoracic and Cardiovascular Surgery 137:1, 30-35
CrossRef161
Pamela M. McMahon, Chung Yin Kong, Milton C. Weinstein, Angela C. Tramontano, Lauren E. Cipriano, Bruce E. Johnson, Jane C. Weeks, G. Scott Gazelle. (2008) Adopting helical CT screening for lung cancer. Cancer 113:12, 3440-3449
CrossRef162
Joe L. Hsu, Dipanjan Banerjee, Ware G. Kuschner. (2008) Understanding and Identifying Bias and Confounding in the Medical Literature. Southern Medical Journal 101:12, 1240-1245
CrossRef163
Omar A. Minai, Sonia Shah, Peter Mazzone, Marie M. Budev, Debasis Sahoo, Sudish Murthy, David Mason, Gosta Pettersson, Atul C. Mehta. (2008) Bronchogenic Carcinoma after Lung Transplantation: Characteristics and Outcomes. Journal of Thoracic Oncology 3:12, 1404-1409
CrossRef164
Tomohiro Hirose, Norihisa Nitta, Junji Shiraishi, Yukihiro Nagatani, Masashi Takahashi, Kiyoshi Murata. (2008) Evaluation of Computer-aided Diagnosis (CAD) Software for the Detection of Lung Nodules on Multidetector Row Computed Tomography (MDCT). Academic Radiology 15:12, 1505-1512
CrossRef165
I Eberini, E Gianazza, U Pastorino, CR Sirtori. (2008) Assessment of individual lung cancer risk by the proteomic analysis of exhaled breath condensate. Expert Opinion on Medical Diagnostics 2:12, 1309-1315
CrossRef166
A.S. Shaw, M.V. Williams. (2008) The cancer reform strategy. Clinical Radiology 63:12, 1292-1296
CrossRef167
Giuseppe Pelosi, Angelica Sonzogni, Giulia Veronesi, Elisa De Camilli, Patrick Maisonneuve, Lorenzo Spaggiari, Michela Manzotti, Michele Masullo, Giulio Taliento, Caterina Fumagalli, Massimo Bellomi, William D. Travis, Maryam Kadivar, Giuseppe Viale. (2008) Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: A baseline and 2-year repeat study. Lung Cancer 62:2, 202-214
CrossRef168
Ken Kodama, Masahiko Higashiyama, Koji Takami, Kazuyuki Oda, Jiro Okami, Jun Maeda, Mitsuhiro Koyama, Tomio Nakayama. (2008) Treatment strategy for patients with small peripheral lung lesion(s): intermediate-term results of prospective study. European Journal of Cardio-Thoracic Surgery 34:5, 1068-1074
CrossRef169
Giuseppe Pelosi, Juan Rosai. (2008) Invited Commentary. The Annals of Thoracic Surgery 86:4, 1090-1091
CrossRef170
M. Souto, P.G. Tahoces, J.J. Suárez Cuenca, M.J. Lado, M. Remy-Jardin, J. Remy, J.J. Vidal. (2008) Detección automática de nódulos pulmonares en tomografía computarizada. Un estudio preliminar. Radiología 50:5, 387-392
CrossRef171
Bruce J. Hillman, Constantine Gatsonis. (2008) The American College of Radiology Imaging Network—Clinical Trials of Diagnostic Imaging and Image-Guided Treatment. Seminars in Oncology 35:5, 460-469
CrossRef172
Pieter E Postmus. (2008) Screening and early diagnosis in lung cancer. Expert Review of Anticancer Therapy 8:10, 1529-1531
CrossRef173
David B. Resnik. (2008) Hidden Sources of Private Industry Funding. The American Journal of Bioethics 8:8, 60-61
CrossRef174
Eric L. Grogan, George J. Stukenborg, Alykhan S. Nagji, Winsor Simmons, Benjamin D. Kozower, David R. Jones, Thomas M. Daniel. (2008) Radiotracer-Guided Thoracoscopic Resection is a Cost-Effective Technique for the Evaluation of Subcentimeter Pulmonary Nodules. The Annals of Thoracic Surgery 86:3, 934-940
CrossRef175
Giulia Veronesi, Massimo Bellomi, Paolo Scanagatta, Lorenzo Preda, Cristiano Rampinelli, Juliana Guarize, Giuseppe Pelosi, Patrick Maisonneuve, Francesco Leo, Piergiorgio Solli, Michele Masullo, Lorenzo Spaggiari. (2008) Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. The Journal of Thoracic and Cardiovascular Surgery 136:3, 611-617
CrossRef176
Peter Mazzone. (2008) Progress in the development of a diagnostic test for lung cancer through the analysis of breath volatiles. Journal of Breath Research 2:3, 037014
CrossRef177
B. van Ginneken. (2008) Computer-Aided Diagnosis in Thoracic Computed Tomography. Imaging Decisions MRI 12:3, 11-22
CrossRef178
Sai Yendamuri, Ara A. Vaporciyan, Tanweer Zaidi, Lei Feng, Ricardo Fernandez, Nebiyou B. Bekele, Wayne L. Hofstetter, Feng Jiang, Reza J. Mehran, David C. Rice, Margaret R. Spitz, Stephen G. Swisher, Garrett L. Walsh, Jack A. Roth, Ruth L. Katz. (2008) 3p22.1 and 10q22.3 Deletions Detected by Fluorescence In Situ Hybridization (FISH). Journal of Thoracic Oncology 3:9, 979-984
CrossRef179
Iván Márquez Rodas, Javier de Miguel Díez, José Luis Álvarez-Sala. (2008) La tomografía por emisión de positrones en el estudio del nódulo pulmonar solitario. Archivos de Bronconeumología 44:9, 493-498
CrossRef180
Kenji TSUSHIMA, Shusuke SONE, Takaomi HANAOKA, Keishi KUBO. (2008) Radiological diagnosis of small pulmonary nodules detected on low-dose screening computed tomography. Respirology 13:6, 817-824
CrossRef181
David E. Gerber. (2008) EGFR inhibition in the treatment of non-small cell lung cancer. Drug Development Research 69:6, 359-372
CrossRef182
Olli S. Miettinen. (2008) Survival analysis: up from Kaplan–Meier–Greenwood. European Journal of Epidemiology 23:9, 585-592
CrossRef183
Henschke, Claudia I., . (2008) Clarifying Enrollment Procedures in the Trial of CT Screening for Lung Cancer. New England Journal of Medicine 359:8, 871-873
Full Text184
J K Field, S W Duffy. (2008) Lung cancer screening: the way forward. British Journal of Cancer 99:4, 557-562
CrossRef185
Kelly M Woodard, Caroline J Chapman. (2008) Lung cancer – can autoantibodies provide an aid to diagnosis?. Expert Opinion on Medical Diagnostics 2:8, 911-923
CrossRef186
Peter Miller, Louisa Strain, Susan Savva. (2008) News and Notes. Addiction 103:8, 1406-1408
CrossRef187
William Jacot, Ludovic Lhermitte, Nadège Dossat, Jean-Louis Pujol, Nicolas Molinari, Jean-Pierre Daurès, Thierry Maudelonde, Alain Mangé, Jérôme Solassol. (2008) Serum Proteomic Profiling of Lung Cancer in High-Risk Groups and Determination of Clinical Outcomes. Journal of Thoracic Oncology 3:8, 840-850
CrossRef188
Rafael Martínez-Monge, María Pagola, Isabel Vivas, José María López-Picazo. (2008) CT-guided permanent brachytherapy for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC). Lung Cancer 61:2, 209-213
CrossRef189
Leonard Fass. (2008) Imaging and cancer: A review. Molecular Oncology 2:2, 115-152
CrossRef190
P. Russo, L. Paleari, P. Granone, A. Cesario, U. Pastorino. (2008) Computed Tomography Screening for Lung Cancer in a High-Risk Population: Update on Current Status. JNCI Journal of the National Cancer Institute 100:14, 1043-1044
CrossRef191
Karien A. M. van den Bergh, Marie‐Louise Essink‐Bot, Eveline M. Bunge, Ernst Th. Scholten, Mathias Prokop, Carola A. van Iersel, Rob J. van Klaveren, Harry J. de Koning. (2008) Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial). Cancer 113:2, 396-404
CrossRef192
Frank C. Detterbeck, Christopher J. Gibson. (2008) Turning Gray: The Natural History of Lung Cancer Over Time. Journal of Thoracic Oncology 3:7, 781-792
CrossRef193
Angela Risch, Christoph Plass. (2008) Lung cancer epigenetics and genetics. International Journal of Cancer 123:1, 1-7
CrossRef194
Michael Phillips, Nasser Altorki, John H.M. Austin, Robert B. Cameron, Renee N. Cataneo, Robert Kloss, Roger A. Maxfield, Muhammad I. Munawar, Harvey I. Pass, Asif Rashid, William N. Rom, Peter Schmitt, James Wai. (2008) Detection of lung cancer using weighted digital analysis of breath biomarkers. Clinica Chimica Acta 393:2, 76-84
CrossRef195
Yao Huang, Dorith Shaham, John H.M. Austin, David F. Yankelevitz, Claudia I. Henschke. (2008) Pulmonary lymphoma identified as a result of low-dose CT screening for lung cancer. Clinical Imaging 32:4, 264-268
CrossRef196
Laura Paleari, Pierluigi Granone, Alfredo Cesario, Patrizia Russo. (2008) Computed tomography screening for lung cancer. Cancer 112:11, 2520-2521
CrossRef197
Chun-Ru Chien, Tony Hsiu-Hsi Chen. (2008) Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography. International Journal of Cancer 122:11, 2594-2599
CrossRef198
Jin Mo Goo, Hans-Ulrich Kauczor, Edwin J. R. van Beek. (2008) Innovation in Chest Radiology. Investigative Radiology 43:6, 339-342
CrossRef199
Y Toyoda, T Nakayama, Y Kusunoki, H Iso, T Suzuki. (2008) Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography. British Journal of Cancer 98:10, 1602-1607
CrossRef200
David A Freedman. (2008) Survival Analysis. The American Statistician 62:2, 110-119
CrossRef201
James T. Dobbins, H. Page McAdams, Devon J. Godfrey, Christina M. Li. (2008) Digital Tomosynthesis of the Chest. Journal of Thoracic Imaging 23:2, 86-92
CrossRef202
Jennifer S. Haas, Craig C. Earle, John E. Orav, Phyllis Brawarsky, Bridget A. Neville, David R. Williams. (2008) Racial Segregation and Disparities in Cancer Stage for Seniors. Journal of General Internal Medicine 23:5, 699-705
CrossRef203
J. R. Molina, P. Yang, S. D. Cassivi, S. E. Schild, A. A. Adjei. (2008) Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship. Mayo Clinic Proceedings 83:5, 584-594
CrossRef204
Heang-Ping Chan, Lubomir Hadjiiski, Chuan Zhou, Berkman Sahiner. (2008) Computer-Aided Diagnosis of Lung Cancer and Pulmonary Embolism in Computed Tomography—A Review. Academic Radiology 15:5, 535-555
CrossRef205
G. Bastarrika Alemañ, P.D. Domínguez Echávarri, J.J. Noguera Tajadura, M. Arraiza Sarasa, B. Zudaire Díaz-Tejeiro, J.J. Zulueta Francés. (2008) Utilidad de la reconstrucción de proyección de máxima intensidad para la lectura de los estudios realizados en un programa de detección precoz de cáncer de pulmón por tomografía computarizada multicorte de baja dosis de radiación. Radiología 50:3, 231-237
CrossRef206
Joan Manel Gasent Blesa, Emilio Esteban González, Vicente Alberola Candel. (2008) Screening and chemoprevention in lung cancer. Clinical and Translational Oncology 10:5, 274-280
CrossRef207
S.-H. Ignatius Ou, Jason A. Zell, Argyrios Ziogas, Hoda Anton-Culver. (2008) Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status. Cancer 112:9, 2011-2020
CrossRef208
Schwartz, Robert S., Curfman, Gregory D., Morrissey, Stephen, Drazen, Jeffrey M., . (2008) Full Disclosure and the Funding of Biomedical Research. New England Journal of Medicine 358:17, 1850-1851
Full Text209
Henschke, Claudia, . (2008) Clarification of Funding of Early Lung Cancer Study. New England Journal of Medicine 358:17, 1862-1862
Full Text210
Benjamin D. Kozower, Bryan F. Meyers, Carolyn E. Reed, David R. Jones, Paul A. Decker, Joe B. Putnam. (2008) Does Positron Emission Tomography Prevent Nontherapeutic Pulmonary Resections for Clinical Stage IA Lung Cancer?. The Annals of Thoracic Surgery 85:4, 1166-1170
CrossRef211
RJ van Klaveren. 2008. Lung cancer screening. , 145-150.
CrossRef212
Robert A. Meguid, Benjamin S. Brooke, David C. Chang, J. Timothy Sherwood, Malcolm V. Brock, Stephen C. Yang. (2008) Are Surgical Outcomes for Lung Cancer Resections Improved at Teaching Hospitals?. The Annals of Thoracic Surgery 85:3, 1015-1025
CrossRef213
Maurizio Infante, Fabio Romano Lutman, Silvio Cavuto, Giorgio Brambilla, Giuseppe Chiesa, Eliseo Passera, Enzo Angeli, Maurizio Chiarenza, Giuseppe Aranzulla, Umberto Cariboni, Marco Alloisio, Matteo Incarbone, Alberto Testori, Anna Destro, Federico Cappuzzo, Massimo Roncalli, Armando Santoro, Gianluigi Ravasi. (2008) Lung cancer screening with spiral CT. Lung Cancer 59:3, 355-363
CrossRef214
Denise R. Aberle, Kathleen Brown. (2008) Lung Cancer Screening with CT. Clinics in Chest Medicine 29:1, 1-14
CrossRef215
Gunnar Hillerdal. (2008) Indolent Lung Cancers???Time for a Paradigm Shift. Journal of Thoracic Oncology 3:3, 208-211
CrossRef216
Y.L. Ng, D. Patsios, H. Roberts, A. Walsham, N.S. Paul, T. Chung, S. Herman, G. Weisbrod. (2008) CT-guided percutaneous fine-needle aspiration biopsy of pulmonary nodules measuring 10 mm or less. Clinical Radiology 63:3, 272-277
CrossRef217
J.-C. Pairon, P. Andujar, M. Matrat, J. Ameille. (2008) Cancers respiratoires professionnels. Revue des Maladies Respiratoires 25:2, 193-207
CrossRef218
Eric J. Wilck. (2008) Computed Tomography Screening for Lung Cancer. The Annals of Thoracic Surgery 85:2, S699-S700
CrossRef219
Eric L. Grogan, David R. Jones, Benjamin D. Kozower, Winsor D. Simmons, Thomas M. Daniel. (2008) Identification of Small Lung Nodules: Technique of Radiotracer-Guided Thoracoscopic Biopsy. The Annals of Thoracic Surgery 85:2, S772-S777
CrossRef220
Sanjay Popat, Yolanda Barbachano, Sue Ashley, Alison Norton, Mary O’Brien. (2008) Erlotinib, docetaxel, and gefitinib in sequential cohorts with relapsed non-small cell lung cancer. Lung Cancer 59:2, 227-231
CrossRef221
B. Housset. (2008) Place des marqueurs biologiques dans le dépistage des cancers thoraciques professionnels. Revue des Maladies Respiratoires 25:2, 254-255
CrossRef222
Chih-Ching Yeh, R. Graham Barr, Charles A. Powell, Sonia Mesia-Vela, Yuanjia Wang, Nada K. Hamade, John H.M. Austin, Regina M. Santella. (2008) No effect of cigarette smoking dose on oxidized plasma proteins. Environmental Research 106:2, 219-225
CrossRef223
A Cassidy, J P Myles, M van Tongeren, R D Page, T Liloglou, S W Duffy, J K Field. (2008) The LLP risk model: an individual risk prediction model for lung cancer. British Journal of Cancer 98:2, 270-276
CrossRef224
L.T. Tanoue. (2008) CT Screening for Lung Cancer: Spiraling Into Confusion?. Yearbook of Medicine 2008, 301-303
CrossRef225
Conor J. Walsh, Nevan C. Hanumara, Alexander H. Slocum, Jo-Anne Shepard, Rajiv Gupta. (2008) A Patient-Mounted, Telerobotic Tool for CT-Guided Percutaneous Interventions. Journal of Medical Devices 2:1, 011007
CrossRef226
Matthias Woenckhaus, Johannes Merk, Robert Stoehr, Frank Schaeper, Andreas Gaumann, Karsten Wiebe, Arndt Hartmann, Ferdinand Hofstaedter, Wolfgang Dietmaier. (2008) Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-–small cell lung cancer. Human Pathology 39:1, 126-136
CrossRef227
S. Diederich. (2008) Screening des Lungenkarzinoms: Stand 2007. Der Radiologe 48:1, 39-44
CrossRef228
Shea M. Eckardt, Rendell W. Ashton. (2008) Lung Cancer Screening: A Clear Voice of Reason. Southern Medical Journal 101:1, 5-6
CrossRef229
Madeline Vazquez. (2008) Reliability of cytologic diagnosis of early lung cancer. Yearbook of Pathology and Laboratory Medicine 2008, 260-263
CrossRef230
Mario Gomez, Gerard A. Silvestri. (2008) Lung Cancer Screening. The American Journal of the Medical Sciences 335:1, 46-50
CrossRef231
Eisuke Matsui. (2008) CT Screening for Lung Cancer 2008 -Is a Stag at Bay a Dangerous Foe?-. Haigan 48:2, 85-92
CrossRef232
N.H. Hanna. (2008) Computed Tomography Screening and Lung Cancer Outcomes. Yearbook of Medicine 2008, 178-179
CrossRef233
ELM Ho, BJJ Abdullah, AAL Tang, AJ Nordin, AR Nair, GCC Lim, H Samad-Cheung, KH Ng, S Ponnusamy, SF Abbas, SI Bux, S Arasaratnam, YF Abdul Aziz, S Venugopal, Z Musa, Z Abdul Manaf. (2008) College of Radiology, Academy of Medicine of Malaysia position on whole body screening CT scans in healthy asymptomatic individuals (2008). Biomedical Imaging and Intervention Journal 4:4,
CrossRef234
Dean H. Conrad, Jesse Goyette, Paul S. Thomas. (2008) Proteomics as a Method for Early Detection of Cancer: A Review of Proteomics, Exhaled Breath Condensate, and Lung Cancer Screening. Journal of General Internal Medicine 23:S1, 78-84
CrossRef235
N.H. Hanna. (2008) Survival of Patients with Stage I Lung Cancer Detected on CT Screening. Yearbook of Medicine 2008, 175-177
CrossRef236
Miwa Okumura. (2008) The Role of Medical X-ray CT Scanner for Diagnosis the Three Most Common Diseases. The Journal of The Institute of Image Information and Television Engineers 62:4, 483-487
CrossRef237
Duo Liu, Kazuo Awai, Yoshinori Funama, Seitaro Oda, Takeshi Nakaura, Yumi Yanaga, Masahiro Hatemura, Koichi Kawanaka, Yasuyuki Yamashita. (2008) Identification and characterization of focal ground-glass opacity in the lungs by high-resolution CT using thin-section multidetector helical CT: experimental study using a chest CT phantom. Radiation Medicine 26:1, 21-27
CrossRef238
Sonia Mesia-Vela, Chih-Ching Yeh, John H.M. Austin, Matthew Dounel, Charles A. Powell, Anthony Reeves, Regina M. Santella, Lori Stevenson, David Yankelevitz, R. Graham Barr. (2008) Plasma carbonyls do not correlate with lung function or computed tomography measures of lung density in older smokers. Biomarkers 13:4, 422-434
CrossRef239
Tapio Vehmas. (2008) Factors influencing the prevalence of pulmonary nodules in lung cancer screening trials: re-evaluation of a CT study. Upsala Journal of Medical Sciences 113:3, 279-286
CrossRef240
C HENSCHKE. 2008. Computed Tomography Screening for Lung Cancer. , 177-190.
CrossRef241
Yoshiharu Ohno, Hisanobu Koyama, Astushi Kono, Mari Terada, Hiroyasu Inokawa, Sumiaki Matsumoto, Kazuro Sugimura. (2007) Influence of detector collimation and beam pitch for identification and image quality of ground-glass attenuation and nodules on 16- and 64-detector row CT systems: Experimental study using chest phantom. European Journal of Radiology 64:3, 406-413
CrossRef242
Lynn T. Tanoue, Scott Gettinger. (2007) Treatment of Lung Cancer in Older Patients. Clinics in Chest Medicine 28:4, 735-749
CrossRef243
William C. Black. (2007) Computed tomography screening for lung cancer: Review of screening principles and update on current status. Cancer 110:11, 2370-2384
CrossRef244
Michael F. McNitt-Gray, Samuel G. Armato, Charles R. Meyer, Anthony P. Reeves, Geoffrey McLennan, Richie C. Pais, John Freymann, Matthew S. Brown, Roger M. Engelmann, Peyton H. Bland, Gary E. Laderach, Chris Piker, Junfeng Guo, Zaid Towfic, David P.-Y. Qing, David F. Yankelevitz, Denise R. Aberle, Edwin J.R. van Beek, Heber MacMahon, Ella A. Kazerooni, Barbara Y. Croft, Laurence P. Clarke. (2007) The Lung Image Database Consortium (LIDC) Data Collection Process for Nodule Detection and Annotation. Academic Radiology 14:12, 1464-1474
CrossRef245
Shusuke Sone, Tomio Nakayama, Takayuki Honda, Kenji Tsushima, Feng Li, Masayuki Haniuda, Yoshiro Takahashi, Takaichiro Suzuki, Takeshi Yamanda, Ryoichi Kondo, Takaomi Hanaoka, Fumiyoshi Takayama, Keishi Kubo, Hajime Fushimi. (2007) Long-term follow-up study of a population-based 1996–1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography. Lung Cancer 58:3, 329-341
CrossRef246
Brenner, David J., Hall, Eric J., . (2007) Computed Tomography — An Increasing Source of Radiation Exposure. New England Journal of Medicine 357:22, 2277-2284
Full Text247
Ryogo Minamimoto, Michio Senda, Kimiichi Uno, Seishi Jinnouchi, Takeshi Iinuma, Kengo Ito, Chio Okuyama, Kazuhiro Oguchi, Masami Kawamoto, Yutaka Suzuki, Eriko Tsukamoto, Takashi Terauchi, Rumi Nakashima, Masami Nishio, Sadahiko Nishizawa, Hiroshi Fukuda, Tsuyoshi Yoshida, Tomio Inoue. (2007) Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey. Annals of Nuclear Medicine 21:9, 481-498
CrossRef248
Roger A. Kemp, Daniel M. Reinders, Bojana Turic. (2007) Detection of Lung Cancer by Automated Sputum Cytometry. Journal of Thoracic Oncology 2:11, 993-1000
CrossRef249
P. Bach, J. Jett, U. Pastorino, M. Tockman, S. Swensen, C. Begg, Maria de Lurdes Carvalho. (2007) Rastreio com tomografia computorizada e resultados no cancro do pulmão. Revista Portuguesa de Pneumologia (English Edition) 13:6, 888-890
CrossRef250
Therese B. Bevers. (2007) CT screening for lung cancer. Current Oncology Reports 9:6, 501-502
CrossRef251
Takeshi Hanagiri, Kenji Sugio, Makiko Mizukami, Yoshinobu Ichiki, Masakazu Sugaya, Kenji Ono, Manabu Yasuda, Tadahiro Nozoe, Mitsuhiro Takenoyama, Kosei Yasumoto. (2007) Postoperative Prognosis in Patients with Non-small Cell Lung Cancer According to the Method of Initial Detection. Journal of Thoracic Oncology 2:10, 907-911
CrossRef252
Rodrigo Córdoba García, Carlos Coscollar Santaliestra. (2007) El cribado de los fumadores llevado a su extremo. A propósito del cáncer de pulmón. Atención Primaria 39:10, 521-523
CrossRef253
Yong Wang, Xueguo Liu, Yujing Lin, Xianping Yi, Lianju Ding, Xiaohong Wang, Qingsi Zeng, Jianxing He, Mingzhu Liang, Peixin Qin, Guomei Zhong, Yanli He, Xiaobin Liu. (2007) The correlation between stroma analysis and MDCT early phase contrast enhancement in small solid lung adenocarcinoma. The Chinese-German Journal of Clinical Oncology 6:5, 419-424
CrossRef254
Silvia Vidal Serrano, Aurora Llanos Méndez. (2007) Cribado de cáncer de pulmón con TC de tórax: revisión sistemática. Medicina Clínica 129:15, 582-587
CrossRef255
S.-H. Ignatius Ou, Jason A. Zell, Argyrios Ziogas, Hoda Anton-Culver. (2007) Prognostic factors for survival of stage I nonsmall cell lung cancer patients. Cancer 110:7, 1532-1541
CrossRef256
Thierry Blanchon, Jeanne-Marie Bréchot, Philippe A. Grenier, Gilbert R. Ferretti, Etienne Lemarié, Bernard Milleron, Dominique Chagué, François Laurent, Yves Martinet, Catherine Beigelman-Aubry, François Blanchon, Marie-Pierre Revel, Sylvie Friard, Martine Rémy-Jardin, Manuela Vasile, Nicola Santelmo, Alain Lecalier, Patricia Lefébure, Denis Moro-Sibilot, Jean-Luc Breton, Marie-France Carette, Christian Brambilla, François Fournel, Alexia Kieffer, Guy Frija, Antoine Flahault. (2007) Baseline results of the Depiscan study: A French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 58:1, 50-58
CrossRef257
Sara C Erridge, Henrik Møller, Allan Price, David Brewster. (2007) International comparisons of survival from lung cancer: pitfalls and warnings. Nature Clinical Practice Oncology 4:10, 570-577
CrossRef258
Sophie Sun, Joan H. Schiller, Monica Spinola, John D. Minna. (2007) New molecularly targeted therapies for lung cancer. Journal of Clinical Investigation 117:10, 2740-2750
CrossRef259
William Chi-Shing Cho. (2007) Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer. Biomedicine & Pharmacotherapy 61:9, 515-519
CrossRef260
Ricardo García Luján, Cristina García Quero. (2007) Análisis de las publicaciones sobre cáncer de pulmón en Archivos de Bronconeumología 2 años después de la designación del Año SEPAR del Cáncer de Pulmón. Archivos de Bronconeumología 43:9, 508-515
CrossRef261
Sang-Man Jin, Seung-Ho Choi, Chul-Gyu Yoo, Young-Whan Kim, Sung-Koo Han, Young-Soo Shim, Sang-Min Lee. (2007) Small solid noncalcified pulmonary nodules detected by screening chest computed tomography. Respiratory Medicine 101:9, 1880-1884
CrossRef262
Thomas E. Stinchcombe, Frank C. Detterbeck, Li Lin, M Patricia Rivera, Mark A. Socinski. (2007) Beliefs among Physicians in the Diagnostic and Therapeutic Approach to Non-small Cell Lung Cancer. Journal of Thoracic Oncology 2:9, 819-826
CrossRef263
Giulia Veronesi, Massimo Bellomi, Umberto Veronesi, Giovanni Paganelli, Patrick Maisonneuve, Paolo Scanagatta, Francesco Leo, Giuseppe Pelosi, Laura Travaini, Cristiano Rampinelli, Giuseppe Trifirò, Angelica Sonzogni, Lorenzo Spaggiari. (2007) Role of Positron Emission Tomography Scanning in the Management of Lung Nodules Detected at Baseline Computed Tomography Screening. The Annals of Thoracic Surgery 84:3, 959-966
CrossRef264
John K. Field, Adrian Cassidy, Jonathan Miles, Triantafillos Liloglou, George Xinarianos, Dawn Smith, Asaf Niaz, Richard Page, Stephen Duffy. (2007) Biomarkers and risk models for stratification of high risk individuals. Journal of Thoracic Oncology 2:Supplement 4, S176
CrossRef265
Matthew J. Budoff, Ambarish Gopal. (2007) Rebuttal: Reviewing large field of views on cardiac CT does not lead to improved outcomes. Catheterization and Cardiovascular Interventions 70:2, 326-328
CrossRef266
Fergus V Gleeson. (2007) Screening for lung cancer with spiral CT is not justified. Nature Clinical Practice Oncology 4:8, 442-443
CrossRef267
Mannudeep K. Kalra, Suhny Abbara, Ricardo C. Cury, Thomas J. Brady. (2007) Interpretation of incidental findings on cardiac CT angiography. Catheterization and Cardiovascular Interventions 70:2, 324-325
CrossRef268
Claudia I Henschke. (2007) CT screening for lung cancer is justified. Nature Clinical Practice Oncology 4:8, 440-441
CrossRef269
Claudia I. Henschke. (2007) International early lung cancer action program. Journal of Thoracic Oncology 2:Supplement 4, S267-S268
CrossRef270
Pyng Lee, Tom G Sutedja. (2007) Lung cancer screening: has there been any progress? Computed tomography and autofluorescence bronchoscopy. Current Opinion in Pulmonary Medicine 13:4, 243-248
CrossRef271
Peter J. Mazzone, Tarek Mekhail. (2007) Lung cancer screening. Current Oncology Reports 9:4, 265-274
CrossRef272
Alissa K Greenberg, M Sung Lee. (2007) Biomarkers for lung cancer: clinical uses. Current Opinion in Pulmonary Medicine 13:4, 249-255
CrossRef273
Bruce J. Hillman. (2007) Author’s Reply. Journal of the American College of Radiology 4:6, 430
CrossRef274
Takayuki Fukui, Noriaki Sakakura, Shoichi Mori, Shunzo Hatooka, Masayuki Shinoda, Yasushi Yatabe, Tetsuya Mitsudomi. (2007) Controversy about Small Peripheral Lung Adenocarcinomas: How Should We Manage Them?. Journal of Thoracic Oncology 2:6, 546-552
CrossRef275
David F. Yankelevitz. (2007) CT Screening for Lung Cancer: Editorials Can Be Deceiving. Journal of the American College of Radiology 4:6, 429-430
CrossRef276
C. Belda-Iniesta, J. Castro Carpeño, J. A. Carrasco, V. Moreno, E. Casado Sáenz, J. Feliu, M. Sereno, F. García Río, J. Barriuso, M. González Barón. (2007) New screening method for lung cancer by detecting volatile organic compounds in breath. Clinical and Translational Oncology 9:6, 364-368
CrossRef277
Emilio Bria, Federica Cuppone, Fabiana Letizia Cecere, Michele Milella, Cecilia Nisticò, Francesco Cognetti, Edmondo Terzoli. (2007) Adjuvant Chemotherapy for Non-small Cell Lung Cancer. Journal of Thoracic Oncology 2:Supplement 1, S7-S11
CrossRef278
Eugenio Paci. (2007) Observational, One-Arm Studies and Randomized Population-Based Trials for Evaluation of the Efficacy of Lung Cancer Screening. Journal of Thoracic Oncology 2:Supplement 1, S45-S46
CrossRef279
Luis Callol, Francisco Roig, Alfredo Cuevas, Jose Ignacio de Granda, Francisco Villegas, Javier Jareño, Eva Arias, Jose M. Albiach. (2007) Low-dose CT: A useful and accessible tool for the early diagnosis of lung cancer in selected populations. Lung Cancer 56:2, 217-221
CrossRef280
J. Timothy SHERWOOD, Malcolm V. BROCK. (2007) Lung cancer: New surgical approaches. Respirology 12:3, 326-332
CrossRef281
Claudia I. Henschke, David F. Yankelevitz, Nasser K. Altorki. (2007) The Role of CT Screening for Lung Cancer. Thoracic Surgery Clinics 17:2, 137-142
CrossRef282
Ugo Pastorino. (2007) Does screening for stage I lung cancer improve survival in a high-risk population?. Nature Clinical Practice Oncology 4:4, 218-219
CrossRef283
Mitsuo Sato, David S. Shames, Adi F. Gazdar, John D. Minna. (2007) A Translational View of the Molecular Pathogenesis of Lung Cancer. Journal of Thoracic Oncology 2:4, 327-343
CrossRef284
Olli S Miettinen. (2007) Curability of lung cancer. Expert Review of Anticancer Therapy 7:4, 399-401
CrossRef285
C. H. Bangma, S. Roemeling, F. H. Schröder. (2007) Overdiagnosis and overtreatment of early detected prostate cancer. World Journal of Urology 25:1, 3-9
CrossRef286
John A. Rumberger. (2007) Reply. Journal of the American College of Cardiology 49:11, 1228
CrossRef287
(2007) CT Screening for Lung Cancer. New England Journal of Medicine 356:7, 743-747
Full Text288
Bruce J. Hillman. (2007) CT Screening for Lung Cancer: Appearances Can Be Deceiving. Journal of the American College of Radiology 4:2, 83-85
CrossRef289
Nobuhiko Seki, Kenji Eguchi, Masahiro Kaneko, Hironobu Ohmatsu, Ryutaro Kakinuma, Eisuke Matsui, Masahiko Kusumoto, Takaaki Tsuchida, Hiroyuki Nishiyama, Noriyuki Moriyama. (2007) What We Can Find Out from Repeated Screening with Low-dose Helical Computed Tomography. Haigan 47:6, 785-789
CrossRef290
(2007) Detection of curable stage I lung cancer by annual CT screening. Nature Clinical Practice Oncology 4:1, 9-9
CrossRef291
M.L. Rosado de Christenson. (2007) Survival of Patients with Stage I Lung Cancer Detected on CT Screening. Yearbook of Diagnostic Radiology 2007, 4-6
CrossRef292
D.R. Jones. (2007) Survival of Patients with Stage I Lung Cancer Detected on CT Screening. Yearbook of Surgery 2007, 372-373
CrossRef293
Kazuto Ashizawa. (2007) Problem of Diagnosis and Follow-up for Pulmonary Nodules Detected on Low-dose CT Screening. Haigan 47:6, 769-776
CrossRef294
D. E. Midthun, S. J. Swensen, T. E. Hartman, J. R. Jett. (2007) Lung Cancer Screening Results: Easily Misunderstood. Mayo Clinic Proceedings 82:1, 14-15
CrossRef295
Unger, Michael, . (2006) A Pause, Progress, and Reassessment in Lung Cancer Screening. New England Journal of Medicine 355:17, 1822-1824
Full Text296
Renée Manser, Louis B Irving, Christine Stone, Graham Byrnes, Michael J Abramson, Donald Campbell, Renée Manser. 2004. Screening for lung cancer. .
CrossRef
- Letters
